Top

Carlos Antonio Torres-Cabala, M.D.

Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

About Dr. Torres-Cabala

I am a Professor in the Departments of Pathology and Dermatology at MD Anderson Cancer Center. I am board certified in Anatomic Pathology (National Cancer Institute, Bethesda, MD) and Dermatopathology (UT MD Anderson Cancer Center) and have a previous residency in Anatomic and Clinical Pathology (Universidad Cayetano Heredia, Lima, Peru). I also obtained a PharmD parallel to my MD studies in Peru, where I completed MS studies in Biochemistry and Molecular Biology.

My research interests comprise cutaneous tumors with emphasis in lymphomas and melanoma. In lymphomas I have conducted studies in rare aggressive primary cutaneous tumors such as gamma/delta T cell lymphoma (expanding the description of the epidermotropic variant) as well as more indolent entities such as lymphomatoid papulosis (type D) and CD4-positive small to medium size T cell lymphoproliferative disorders. In melanoma, i have focused in acral lentiginous melanoma for which we described KITmutation and protein expression status in a large series of cases and described TERTamplification in progression to metastasis. I have presented my research and taught in many national and international conferences and courses. Currently, I served as Section Chief of Dermatopathology and I am a member of the executive committee of the International Society of Dermatopathology.

Primary Appointment

Professor (Joint Appointment), Department of Dermatology, Division of Internal Medicine, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor (Joint Appointment), Department of Translational Molecular Pathology, Division of Pathology and Laboratory Medicine, The University of Texas Medical Branch, Houston, Texas

Professor, Department of Pathology, Anatomical, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Research Interests

My research interest include cutaneous tumors, for which melanoma and cutaneous lymphomas are of special interest to me.

In melanoma, I am particularly interested in acral lentiginous melanoma, a rare and aggressive type that occurs in locations such as palms and soles. It is a unique variant that seems to be biologically distinct from the more common sun damage-associated melanomas. We studied a large series of cases in which we described the mutational and protein expression status of KIT.Other gene implicated in this tumor is TERT,that appears to be increasingly amplified in metastatic acral melanoma. Interestingly, we noticed that non-acral melanomas also show amplification of TERT, contrary to what has been traditionally accepted. Our efforts to elucidate the biology of acral melanoma continue by mentoring junior colleagues within our Section. An update in our knowledge of melanoma was published in our book, Genetics of Melanoma, edited with my colleague Dr. J. Curry.

In cutaneous lymphomas, our studies have expanded our understanding of elusive entities such as "type D" lymphomatoid papulosis, CD4-positive small to medium size T cell lymphoproliferative disorders, and others. Our comprehensive description of the epidermotropic variant of primary cutaneous gamma/delta T cell lymphoma has been recently validated by reports of a different cell of origin of this tumor, as our clinical-pathological data suggested.

Clinical Interests

My clinical interests include tumoral and non-tumoral entities in the setting of a tertiary cancer center. In my daily practice, which is mostly devoted to pathology diagnosis, I evaluate a wide range of cutaneous tumors including challenging melanocytic lesions, squamous proliferations, adnexal benign and malignant tumors, hematolymphoid proliferations in the skin, and others. Inflammatory conditions such as graft-versus-host disease, drug reactions, and paraneoplastic diseases are also routinely diagnosed. I am particularly interested in hematolymphoid lesions in the skin and actively participate and organize clinical pathological conferences in coordination with my Dermatology and Lymphoma/Leukemia colleagues. I am also deeply involved in clinical evaluation of melanoma cases and maintain close relationship with our colleagues from Melanoma Medical Oncology and Surgery.

Education & Training

Degree-Granting Education

1994	Universidad Nacional de San Agustin, School of Medicine, Arequipa, PE, Medicine, MD
1992	Universidad Catolica Santa Maria, School of Pharmacy and Biochemistry, Arequipa, PE, Pharmacy and Biochemistry, PharmD

Postgraduate Training

2007-2008	Clinical Fellow, Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
2004-2007	Clinical Resident, Anatomic Pathology, National Institutes of Health, National Cancer Institute, Bethesda, Maryland
2001-2004	Postdoctoral Research Fellow, Molecular Pathology, National Institutes of Health, National Cancer Institute, Bethesda, Maryland
1996-2000	Clinical Resident, Anatomic and Clinical Pathology, Universidad Peruana Cayetano Heredia, Hospital Nacional Cayetano Heredia, Lima
1994-1997	Master of Sciences Candidate, Biochemistry and Molecular Biology, Universidad Nacional de San Agustin, School of Medicine, Arequipa
1993-1994	Intern, Internal Medicine, Surgery, Pediatrics, Obstetrics and Gynecology, Universidad Nacional de San Agustin School of Medicine, Arequipa

Board Certifications

2008	American Board of Pathology and American Board of Dermatology, Dermatopathology
2007	American Board of Pathology, Anatomic Pathology

Experience & Service

Academic Appointments

Associate Professor, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2018

Associate Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2018

Assistant Professor, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2014

Assistant Professor, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2014

Instructor, Department of Pathology, Universidad Peruana Cayetano Heredia, Lima, 1999 - 1999

Assistant Professor, Department of Physiological Sciences-Biochemistry, Universidad Nacional de San Agustin, Arequipa, 1995 - 1996

Administrative Appointments/Responsibilities

Member, Appropriate Use Criteria Committee, The American Society of Dermatopathology, Deerfield, IL, 2021 - Present

Co-Director, Translational Molecular Pathology Dermatopathology Laboratory, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2020 - Present

Member, Membership Awards Committee, The American Society of Dermatopathology, Deerfield, IL, 2017 - 2019

Chief, Dermatopathology Section, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2016 - Present

Member, Harris County Medical Society Membership Committee, Houston, TX, 2016 - 2018

Member, Executive Committee, International Society of Dermatopathology, Half Moon Bay, CA, 2013 - Present

Member, Committee of International Partnering, The American Society of Dermatopathology, Deerfield, IL, 2011 - 2015

Secretary/Treasurer, Latin American Pathology Foundation, New Orleans, LA, 2009 - 2010

Other Appointments/Responsibilities

Collaborator, Core B, Informatics, Tissue Resource and Pathology Core, Melanoma SPORE, Houston, TX, 2008 - Present

Institutional Committee Activities

Member, Dermatology Chair Recruitment Search Committee, 2023 - 2024

Member, Melanoma Medical Oncology Clinical Faculty Recruitment Search Committee, 2022 - 2022

Member, Appropriate Use Criteria, 2021 - Present

Member, The University of Texas MD Anderson Cancer Center Bridge Funding Advisory Committee, 2020 - Present

Member, Bridge Funding Advisory Committee, 2020 - Present

Member, National Comprehensive Cancer Network, 2018 - Present

Member, Clinical Competency Commitee, 2018 - Present

Member, Mentorship Awards, 2017 - 2019

Chair, Program Evaluation Committee, 2016 - 2018

Member, Executive Committee, 2013 - 2021

Member, The University of Texas MD Anderson Cancer Center Clinical Research Committee (CRC) 4, 2012 - 2015

Member, Study Section Review Committee for Clinical Translational and Population-Based Research Projects under the Institutional Research Grants (IRG) Program, 2011 - Present

Representative, Department of Pathology, Faculty Senate of The University of Texas MD Anderson Cancer Center, 2011 - 2014

Member, International Partnering, 2011 - 2015

Member, The University of Texas MD Anderson Cancer Center Clinical Research Committee (CRC) 2, 2010 - 2012

Dermatopathology Representative, Department of Pathology Committee for the ACGME Site Visit/Evaluation of The University of Texas MD Anderson Cancer Center Special Surgical Pathology Fellowship Program, 2010 - Present

Honors & Awards

2020	Faculty Recognition Award for Excellence in Patient Care, inaugural recipient, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center
2006	Travel Award, International Society of Urological Pathology
2004	Merit Stowell-Orbison Award, United States and Canadian Academy of Pathology

Professional Memberships

Houston Society of Clinical Pathologists

2023 - Present

Iberoamerican Association of Telehealth and Telemedicine

2022 - Present

Mentorship Program Committee, Peruvian American Medical Society

2022 - Present

International Society of Cutaneous Lymphomas

2020 - Present

United States Cutaneous Lymphoma Consortium

2017 - Present

American Society of Dermatopathology

2013 - Present

Latin American Pathology Foundation

2009 - 2010

International Society of Dermatopathology

2009 - Present

Harris County Medical Society

2008 - Present

Texas Medical Association

2008 - Present

American Society for Clinical Pathology

2007 - Present

College of American Pathologists

2006 - Present

American Medical Association

2006 - Present

Peruvian American Medical Society

2004 - Present

International Union Against Cancer (UICC)

2004 - 2009

American Society for Investigative Pathology

2003 - 2009

United States and Canadian Academy of Pathology (USCAP)

2002 - Present

Edmundo Escomel Scientific Association

1990 - 1996

Selected Publications

Peer-Reviewed Articles

Pineda-Reyes J, Arudra SK, Aung PP, Nagarajan P, Curry JL, Tetzlaff M, Prieto VG, Wang WL, Hwu WJ, Torres-Cabala CA. Dual PD-L1/SOX10 Immunohistochemistry Combined With Digital Imaging Enhances Stratification Accuracy of Patients With Metastatic Melanoma. Am J Surg Pathol 48(12):1551-1556, 2024. e-Pub 2024. PMID: 39373029.
Turcios Escobar, S, Yang, RK, Nelson, KC, Gershenwald, JE, Tawbi, H, Aung, PP, Patel, SP, Torres Cabala, CA. Utility of next-generation sequencing in the diagnosis of metastatic melanoma. Journal of cutaneous pathology 51(9):644-648, 2024. e-Pub 2024. PMID: 38757469.
Wu SY, Damron EP, Xu J, Fang PQ, Dai J, Nair R, Malpica Castillo LE, Fayad LE, Torres-Cabala CA, Medeiros LJ, Vega F, Miranda RN, Duvic M, Pinnix CC, Dabaja BS, Iyer SP, Huen AO, Gunther JR. Radiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. Int J Dermatol 64(2):385-389, 2024. e-Pub 2024. PMID: 38955474.
Giubellino A, He Y, Munro SA, Zhou Y, Song KY, Plaza JA, Torres-Cabala CA, Nelson AC. Gene Expression Profile of Benign, Intermediate, and Malignant Spitz and Spitzoid Melanocytic Lesions. Cancers (Basel) 16(10), 2024. e-Pub 2024. PMID: 38791877.
Cho WC, Saade R, Nagarajan P, Aung PP, Milton DR, Marques-Piubelli ML, Hudgens C, Ledesma D, Nelson K, Ivan D, Zhang M, Torres-Cabala CA, Campbell M, Alhalabi O, Prieto VG, Wistuba II, Esmaeli B, Curry JL. Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin. J Cutan Pathol 51(5):360-367, 2024. e-Pub 2024. PMID: 38200650.
Liu YA, Aung PP, Wang Y, Ning J, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Ding Q, Cho WC. TRPS1 expression in non-melanocytic cutaneous neoplasms: an immunohistochemical analysis of 200 cases. J Pathol Transl Med 58(2):72-80, 2024. e-Pub 2024. PMID: 38389280.
Marques-Piubelli ML, Navarrete J, Ledesma DA, Hudgens CW, Lazcano RN, Alani A, Huen A, Duvic M, Nagarajan P, Aung PP, Wistuba II, Curry JL, Miranda RN, Torres-Cabala CA. Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells 13(5), 2024. e-Pub 2024. PMID: 38474383.
Liu YA, Collins K, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC. TRPS1 expression in primary and secondary extramammary Paget diseases: An immunohistochemical analysis of 93 cases. Hum Pathol 143:5-9, 2024. e-Pub 2024. PMID: 38000676.
Giubellino A, Torres-Cabala C. Editorial for Special Issue "Molecular Mechanisms and Signaling Pathways in Melanoma". Cancers (Basel) 15(19), 2023. e-Pub 2023. PMID: 37835369.
Cho WC, Li W, Gu J, Wang WL, Ning J, Sfamenos S, Gill P, Nagarajan P, Curry JL, Lazar AJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma. J Cutan Pathol 50(9):845-851, 2023. e-Pub 2023. PMID: 37400233.
Vanderbeck K, Rothrock AT, Cho WC, Nagarajan P, Aung PP, Hudgens C, Bassett RL, Ivan D, Prieto VG, Curry JL, Torres-Cabala CA. PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls. Am J Dermatopathol 45(8):549-556, 2023. e-Pub 2023. PMID: 37462205.
Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma. Arch Pathol Lab Med 147(7):758-766, 2023. e-Pub 2023. PMID: 36745184.
Hasanov M, Milton DR, Bea Davies A, Sirmans E, Saberian C, Posada EL, Opusunju S, Gershenwald JE, Torres-Cabala CA, Burton EM, Colen R, Huse JT, Glitza Oliva IC, Chung C, McAleer MF, McGovern SL, Yeboa DN, Kim BYS, Prabhu SS, McCutcheon IE, Weinberg J, Lang FF, Tawbi HA, Li J, Haydu LE, Davies MA, Ferguson SD. Changes In Outcomes And Factors Associated With Survival In Melanoma Patients With Brain Metastases. Neuro Oncol 25(7):1310-1320, 2023. e-Pub 2023. PMID: 36510640.
Marques-Piubelli ML, Seervai RNH, Mudaliar KM, Ma W, Milton DR, Wang J, Muhlbauer A, Parra ER, Solis LM, Nagarajan P, Speiser J, Hudgens C, Cho WC, Aung PP, Patel A, Pacha O, Nelson KC, Tetzlaff MT, Amaria RN, Torres-Cabala CA, Prieto VG, Wistuba II, Curry JL. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of TH 1 T-cells. J Cutan Pathol 50(7):661-673, 2023. e-Pub 2023. PMID: 37150813.
Song KY, Han YH, Roehrich H, Brown ME, Torres-Cabala C, Giubellino A. MET Receptor Tyrosine Kinase Inhibition Reduces Interferon-Gamma (IFN-γ)-Stimulated PD-L1 Expression through the STAT3 Pathway in Melanoma Cells. Cancers (Basel) 15(13), 2023. e-Pub 2023. PMID: 37444518.
Cho WC, Ding Q, Wang WL, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Albarracin CT, Sahin A, Prieto VG, Aung PP. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics. J Cutan Pathol 50(5):434-440, 2023. e-Pub 2023. PMID: 36808637.
Amaria RN, Postow M, Burton EM, Tetzlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 615(7953):E23, 2023. e-Pub 2023. PMID: 36894629.
Mendoza R, Quiñones MP, Beltrán BE, Castro D, Paredes S, Miranda RN, Moisés C, Sánchez G, Castillo JJ, Torres-Cabala C. Primary cutaneous Epstein-Barr virus-positive B-cell lymphoid proliferation with features of diffuse large B-cell lymphoma and mucocutaneous ulcer: a diagnostic dilemma. (*Mentor of an international Pathology resident). Int J Dermatol 62(2):e87-e90, 2023. e-Pub 2023. PMID: 35064673.
Fang H, Khoury JD, Torres-Cabala CA, Ng SB, Xu J, El Hussein S, Hu S, Vega F, Li S, Tang Z, Tang G, Medeiros LJ, Wang W. Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms. Pathology 54(7):893-899, 2022. e-Pub 2022. PMID: 35864006.
Cho WC, Nagarajan P, Ding Q, Prieto VG, Torres-Cabala CA. Trichorhinophalangeal Syndrome Type 1-Positive Cells in Breast Dermal Granulation Tissues and Scars: A Potential Diagnostic Pitfall. Am J Dermatopathol 44(12):964-967, 2022. e-Pub 2022. PMID: 35925150.
Amaria RN, Postow M, Burton EM, Tezlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611(7934):155-160, 2022. e-Pub 2022. PMID: 36289334.
Rothrock AT, Torres-Cabala CA, Milton DR, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Ivan D, Prieto VG, Aung PP. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions. J Cutan Pathol 49(10):859-867, 2022. e-Pub 2022. PMID: 35794643.
Guitart J, Mangold AR, Martinez-Escala ME, Walker CJ, Comfere NI, Pulitzer M, Rieger KE, Torres-Cabala CA, Pincus LB, Kumar ES, Wang EBK, Park KE, Espinosa ML, Duvic M, Kim YH, Horwitz S. Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders. JAMA Dermatol 158(10):1167-1174, 2022. e-Pub 2022. PMID: 36001337.
Rothrock AT, Truong LD, Shehabeldin A, Wong MKK, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Amyloid deposition with a granulomatous reaction in a resection specimen: A clue for a preexisting Merkel cell carcinoma. J Cutan Pathol 49(9):787-790, 2022. e-Pub 2022. PMID: 35734844.
Farah M, Milton, Gross ND, Nagarajan P, Gu J, Curry JL, Ivan D, Torres-Cabala CA, Myers JN, Prieto VG, Aung PP. Histopathologic Features Predictive of Metastasis and Survival in 230 Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck and Non-Head and Neck Locations: A Single-Center Retrospective Study. J Eur Acad Dermatol Venereol 36(8):1246-1255, 2022. e-Pub 2022. PMID: 35426183.
Joshi TP, Duvic M, Torres-Cabala CA, Tschen J. Treatment With Dupilumab for Refractory Cutaneous B-Cell Pseudolymphoma. JAMA Dermatol 158(6):697-699, 2022. e-Pub 2022. PMID: 35416914.
Creasy CA, Meng YJ, Forget MA, Karpinets T, Tomczak K, Stewart C, Torres-Cabala CA, Pilon-Thomas S, Sarnaik AA, Mule JJ, Garraway L, Bustos M, Zhang J, Patel SP, Diab A, Glitza IC, Yee C, Tawbi H, Wong MK, McQuade J, Hoon DSB, Davies MA, Hwu P, Amaria RN, Haymaker C, Beroukhim R, Bernatchez C. Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma. Clin Cancer Res 28(9):1911-1924, 2022. e-Pub 2022. PMID: 35190823.
Mantilla-Rojas C, Velasquez FC, Morton JE, Clemente LC, Parra ER, Torres-Cabala C, Sevick-Muraca EM. Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy. Cancers (Basel) 14(7), 2022. e-Pub 2022. PMID: 35406595.
Guitart J, Chung C, Torres-Cabala CA. The dilemma of primary γδ epidermotropic T-cell lymphoma: Distinction from mycosis fungoides, signs of cytotoxicity, and need for more detailed analysis. J Cutan Pathol 49(4):419-420, 2022. e-Pub 2022. PMID: 35080039.
Alvarez P, Torres-Cabala C, Gotuzzo E, Bravo F. Cutaneous balamuthiasis: A clinicopathological study. JAAD Int 6:51-58, 2022. e-Pub 2022. PMID: 35059659.
Cho WC, Gill P, Nagarajan P, Aung PP, Torres-Cabala CA, Curry JL, Ivan D, Lester L, Prieto VG. Cutaneous Lymphoid Hyperplasia With T-Cell Clonality and Monotypic Plasma Cells Secondary to a Tick Bite: A Hidden Critter and the Power of Deeper Levels. Am J Dermatopathol 44(3):226-229, 2022. e-Pub 2022. PMID: 35050559.
Giubellino A, Nelson AC, He Y, Munro SA, Song KY, Glitza Oliva IC, Torres-Cabala C. Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus-like features (*Mentor of a junior colleague). Pigment Cell Melanoma Res 35(2):229-237, 2022. e-Pub 2022. PMID: 34633770.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H. T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20(3):285-308, 2022. e-Pub 2022. PMID: 35276674.
Saleh M, Javadi S, Elsherif S, Patnana M, Sagebiel TL, Torres-Cabala C, Mattei J, Bhosale P, Faria SC. Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to Treatment. Radiographics 42(2):E81, 2022. e-Pub 2022. PMID: 35230922.
Starling CT, Messer AA, Kleiman A, McQuade JL, Glitza IC, Torres-Cabala CA, Heberton M. Interstitial granulomatous dermatitis and concurrent immunotherapy associated encephalitis with nivolumab and ipilimumab. Dermatology Online Journal-Case Presentation 28(2), 2022. e-Pub 2022.
El Hussein S, Wang W, Wang SA, Loghavi S, Wang X, Qiu L, Fang H, Medeiros LJ, Aung PP, Torres Cabala C, Jorgensen JL, Pemmaraju N, Khoury JD. Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia: Illustration of morphologic and immunophenotypic challenges of an emerging phenomenon. Leuk Lymphoma 62(13):3296-3299, 2021. e-Pub 2021. PMID: 34304666.
Ronen S, Al-Rohil RN, Keiser E, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Middleton LP, Torres-Cabala CA, Gershenwald JE, Aung PP, Prieto VG. Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management. Arch Pathol Lab Med 145(12):1505-1515, 2021. e-Pub 2021. PMID: 33577643.
Saleh M, Javadi S, Elsherif S, Patnana M, Sagebiel TL, Torres-Cabala C, Matei J, Bhosale P, Faria SC. Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to Treatment. Radiographics 41(7):1954-1972, 2021. e-Pub 2021. PMID: 34678102.
Cho WC, Gill P, Aung PP, Gu J, Nagarajan P, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. The utility of digital pathology in improving the diagnostic skills of pathology trainees in commonly encountered pigmented cutaneous lesions during the COVID-19 pandemic: A single academic institution experience. (*Mentor of a Dermatopathology Fellow). Ann Diagn Pathol 54:151807, 2021. e-Pub 2021. PMID: 34418768.
Wu C, Peng S, Pilie PG, Geng C, Park S, Manyam GC, Lu Y, Yang G, Tang Z, Kondraganti S, Wang D, Hudgens CW, Ledesma DA, Marques-Piubelli ML, Torres Cabala CA, Curry JL, Troncoso P, Corn PG, Broom BM, Thompson TC. PARP and CDK4/6 inhibitor combination therapy induces apoptosis and suppresses neuroendocrine differentiation in prostate cancer. Mol Cancer Ther 20(9):1680-1691, 2021. e-Pub 2021. PMID: 34158347.
Mehta R, Torres Cabala CA, DiNardo CD, Daver N, Dabaja B, Rezvani K, Champlin RE, Shpall E, Duvic M. Post-transplantation donor-derived Sezary syndrome in a patient with A91V PRF1 variant Hemophagocytic lymphohistiocytosis. Am J Hematol 96(9):E350-E353, 2021. e-Pub 2021. PMID: 34096089.
Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? (*Mentor of a Pathology Fellow). Virchows Arch 479(2):377-383, 2021. e-Pub 2021. PMID: 33604757.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Nagarajan P, Curry JL, Ciurea AM, Rubin AI, Hwu WJ, Prieto VG, Aung PP. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma. Arch Pathol Lab Med 145(8):943-952, 2021. e-Pub 2021. PMID: 33290520.
Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma. Arch Pathol Lab Med 145(7):842-850, 2021. e-Pub 2021. PMID: 33053175.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer. Mod Pathol 34(4):710-719, 2021. e-Pub 2021. PMID: 33011748.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma. Mod Pathol 34(3):572-583, 2021. e-Pub 2021. PMID: 32759976.
Hong BY, Ford JR, Glitza IC, Torres Cabala CA, Tetzlaff M, Prieto VG, Parker R, Daniel C, Esmaeli B. Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma. Ophthalmic Plast Reconstr Surg 37(1):e9-e13, 2021. e-Pub 2021. PMID: 32618825.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kim YH, Mehta-Shah N, Olsen EA, Pro B, Rajguru SA, Rozati S, Said J, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H. NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021. J Natl Compr Canc Netw 18(11):1460-1467, 2020. e-Pub 2020. PMID: 33152703.
Farah M, Reuben A, Spassova I, Yang RK, Kubat L, Nagarajan P, Ning J, Li W, Aung PP, Curry JL, Torres-Cabala CA, Hudgens CW, Ugurel S, Schadendorf D, Gumbs C, Little LD, Futreal A, Wistuba II, Prieto VG, Wang L, Wong MK, Wargo JA, Becker JC, Tetzlaff MT. T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell Carcinoma. J Invest Dermatol 140(11):2146-2156, 2020. e-Pub 2020. PMID: 32304704.
Aung PP, Pemmaraju N, Torres-Cabala CA, Duvic M, Konopleva M, Khoury JD, Prieto VG. Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall. J Dermatol 47(10):e354-e355, 2020. e-Pub 2020. PMID: 32770556.
Tran J, Duvic M, Torres-Cabala CA. Lymphomatoid Papulosis With a Unique T Follicular Helper-Like Phenotype (*Mentor of a Medical Student). Am J Dermatopathol 42(10):776-779, 2020. e-Pub 2020. PMID: 32568843.
Ramani NS, Aung PP, Gu J, Sfamenos S, Sdringola-Maranga C, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Diab A, Prieto VG, Hwu WJ, Torres-Cabala CA. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis (*Mentoring of a Pathology Fellow). Mod Pathol 33(10):2067-2074, 2020. e-Pub 2020. PMID: 32404956.
Vougiouklakis T, Aung PP, Vasudevaraja V, Prieto VG, Torres-Cabala CA, Sulman EP, Snuderl M, Jour G. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors. Sci Rep 10(1):12996, 2020. e-Pub 2020. PMID: 32747660.
Ramachandran V, Park KE, Torres-Cabala CA, Duvic M. Second primary malignancies in subcutaneous panniculitis-like T-cell lymphoma: a national database study. Clin Exp Dermatol 45(6):755-757, 2020. e-Pub 2020. PMID: 32359183.
Yildiz P, Aung PP, Milton DR, Hruska C, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala C, Prieto VG. Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data?. Am J Dermatopathol 42(5):337-342, 2020. e-Pub 2020. PMID: 31464719.
Mehta-Shah N, Horwitz SM, Anseli S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Fisher K, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Lunning MA, Mehta A, Olsend EA, Pro B, Raiguru SA, Shanbhag S, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala CA, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H, Kim YH. NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020. Journal of the National Comprehensive Cancer Network 18(5):522-536, 2020. e-Pub 2020.
Chen PL, Neishaboori N, Tetzlaff MT, Chen WS, Aung PP, Curry JL, Nagarajan P, Ivan D, Hwu WJ, Prieto VG, Torres-Cabala CA. BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma (*Mentoring of a Dermatopathology Fellow). Am J Dermatopathol 42(5):313-321, 2020. e-Pub 2020. PMID: 32310893.
Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol 33(3):496-513, 2020. e-Pub 2020. PMID: 31383963.
Farah M, Nelson KC, Tetzlaff MT, Nagarajan P, CA T, Prieto VG, Curry JL, Aung PP. Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report. J Cutan Pathol, 2020. e-Pub 2020.
Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. Cancers (Basel) 11(12), 2019. e-Pub 2019. PMID: 31888295.
Castaneda CA, Castillo M, Aliaga K, Bernabe LA, Casavilca S, Sanchez J, Torres-Cabala CA, Gomez HL, Mas L, Dunstan J, Cotrina JM, Abugattas J, Chavez I, Ruiz E, Montenegro P, Rojas V, Orrego E, Galvez-Nino M, Felix B, Landa-Baella MP, Vidaurre T, Villa MR, Zevallos R, Taxa L, Guerra H. Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies. Biomark Med 13(17):1481-1491, 2019. e-Pub 2019. PMID: 31621387.
Namikawa K, Aung PP, Milton DR, Tetzlaff MT, Torres Cabala CA, Curry JL, Nagarajan P, Ivan D, Ross MI, Gershenwald JE, Prieto VG. Correlation of tumor burden in sentinel lymph nodes with tumor burden in non-sentinel lymph nodes and survival in cutaneous melanoma. Clin Cancer Res 15(25):7585-7593, 2019. e-Pub 2019. PMID: 31570567.
Mejbel HA, Arudra SKC, Pradhan D, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Duose DY, Luthra R, Prieto VG, Ballester LY, Aung PP. Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity. Cancers (Basel) 11(11), 2019. e-Pub 2019. PMID: 31684113.
Castaneda CA, Castillo M, Torres-Cabala CA, Bernabe LA, Casavilca S, Villegas V, Sanchez J, de la Cruz M, Dunstan J, Cotrina JM, Gomez HL, Chavez C, Landa-Baella MP, Tello K, Felix BF, Abugattas J. Relationship between tumor-associated immune infiltrate and p16 staining over clinicopathological features in acral lentiginous melanoma (*Pathology mentor of an international working group). Clin Transl Oncol 21(9):1127-1134, 2019. e-Pub 2019. PMID: 30778854.
Curry JL, Reuben A, Szczepaniak-Sloane R, Ning J, Milton DR, Lee CH, Hudgens C, George S, Torres-Cabala CA, Johnson D, Subramanya S, Wargo JA, Mudaliar K, Wistuba II, Prieto VG, Diab A, Tetzlaff MT. Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response. J Cutan Pathol 46(9):627-636, 2019. e-Pub 2019. PMID: 30883858.
Mauzo SH, Tetzlaff MT, Nelson K, Amaria R, Patel S, Aung PP, Nagarajan P, Torres-Cabala CA, Diab A, Prieto VG, Curry JL. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. Int J Dermatol 58(9):1045-1052, 2019. e-Pub 2019. PMID: 29152725.
Ibarra BS, Huen A, Nagarajan P, Torres-Cabala CA, Prieto VG, Aung PP. From mycosis fungoides to herpetic folliculitis: The significance of deeper H&E tissue sections in dermatopathology. J Cutan Pathol 46(8):624-626, 2019. e-Pub 2019. PMID: 30883857.
Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres Cabala CA, Efstathiou E, Hoang A, Wong MKK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba II, Tetzlaff MT. B7-H3 expression in Merkel cell carcinoma-associated endothelial cells correlates with locally aggressive primary tumor features and increased vascular density. Clin Cancer Res 25(11):3455-3467, 2019. e-Pub 2019. PMID: 30808776.
Aung PP, Sukswai N, Nejati R, Loghavi S, Chen W, Torres-Cabala CA, Yin CC, Konopleva M, Zheng X, Wang J, Tang Z, Medeiros LJ, Prieto VG, Pemmaraju N, Khoury JD. PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel) 11(5), 2019. e-Pub 2019. PMID: 31109153.
Mauzo SH, Tetzlaff MT, Milton DR, Siroy AE, Nagarajan P, Torres-Cabala CA, Ivan D, Curry JL, Hudgens CW, Wargo JA, Sahin AA, Pettaway CA, Prieto VG, Aung PP. Expression of PD-1 and PD-L1 in Extramammary Paget Disease: Implications for Immune-Targeted Therapy. Cancers (Basel) 11(6), 2019. e-Pub 2019. PMID: 31146499.
Trinidad CM, Torres-Cabala CA, Prieto VG, Aung PP. Update on eighth edition American Joint Committee on Cancer classification for Merkel cell carcinoma and histopathological parameters that determine prognosis. J Clin Pathol 72(5):337-340, 2019. e-Pub 2019. PMID: 30636696.
Trinidad CM, Torres-Cabala CA, Curry JL, Prieto VG, Aung PP. Update on eighth edition American Joint Committee on Cancer classification for cutaneous melanoma and overview of potential pitfalls in histological examination of staging parameters. J Clin Pathol 72(4):265-270, 2019. e-Pub 2019. PMID: 30275100.
Jour G, Vasudevaraja V, Prieto VG, Snuderl M, Torres-Cabala CA, Al-Rohil R, Sulman EP, Ballester LY, Aung PP. BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor. Mod Pathol 32(3):338-345, 2019. e-Pub 2019. PMID: 30310175.
Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series *Mentor of a junior colleague. Am J Dermatopathol 41(3):167-179, 2019. e-Pub 2019. PMID: 30801340.
Konopinski JC, Danialan R, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Prieto VG, Aung PP. Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma. Hum Pathol 84:270-274, 2019. e-Pub 2019. PMID: 30359637.
McQuade JL, Homsi J, Torres-Cabala CA, Bassett R, Popuri RM, James ML, Vence LM, Hwu WJ. A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma *Pathology support of immune-oncology working group. BMC Cancer 18(1):1274, 2018. e-Pub 2018. PMID: 30567529.
Arudra K, Patel R, Tetzlaff MT, Hymes S, Subbiah V, Torres-Cabala CA, Aung PP, Nagarajan P, Diab A, Prieto VG, Nelson K, Curry JL. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. Journal of Cutaneous Pathology 45(10):786-790, 2018. e-Pub 2018. PMID: 30021048.
Forget MA, Haymaker C, Hess KR, Meng YJ, Creasy C, Karpinets TV, Fulbright OJ, Roszik J, Woodman SE, Kim YU, Sakellariou-Thompson D, Bhatta A, Wahl A, Flores E, Thorsen ST, Tavera RJ, Ramachandran R, Gonzalez AM, Toth C, Wardell S, Mansaray R, Patel V, Carpio DJ, Vaughn CS, Farinas CM, Velasquez PG, Hwu WJ, Patel SP, Davies MA, Diab A, Glitza IC, Tawbi H, Wong MKK, Cain S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Wargo JA, Radvanyi LG, Torres Cabala CA, Beroukhim R, Hwu P, Amaria RN, Bernatchez C. Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome (*Pathology support of a multi-department working groups). Clin Cancer Res 24(18):4416-4428, 2018. e-Pub 2018. PMID: 29848573.
Trinidad CM, Nelson KC, Glitza-IC, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Ivan D, Prieto VG, Curry JL, Aung PP. Dermatologic toxicity from immune checkpoint blockade therapy with an interstitial granulomatous pattern. Journal of Cutaneous Pathology 45(7):504-507, 2018.
Dolkar T, Trinidad CM, Nelson KC, Amaria RN, Nagarajan P, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Curry JL, Aung PP. Dermatologic Toxicity from Novel Therapy using Antimicrobial Peptide LL-37 in Melanoma: A Detailed Examination of the Clinicopathologic Features. J Cutan Pathol 45(7):539-544, 2018. e-Pub 2018. PMID: 29665030.
Beltran BE, Quiñones P, Sanchez G, Paredes A, Moises C, Cotrina E, Torres-Cabala CA, Miranda RN, Castillo JJ. Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?. Leuk Lymphoma 59(7):1753-1755, 2018. e-Pub 2018. PMID: 29081245.
Al-Rohil RN, Milton DR, Nagarajan P, Curry JL, Feldmeyer L, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Intratumoral and Peritumoral Lymphovascular Invasion Detected by D2-40 Immunohistochemistry Correlates with Metastasis in Primary Cutaneous Merkel Cell Carcinoma. Hum Pathol 77:98-107, 2018. e-Pub 2018. PMID: 29601841.
Mauzo SH, Milton DR, Prieto VG, Torres-Cabala CA, Wang WL, Chakravarti N, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Brown RE, Aung PP. Summary of Expression of SPARC Protein in Cutaneous Vascular Neoplasms and Mimickers. Ann Diagn Pathol 34:151-154, 2018. e-Pub 2018. PMID: 29660567.
Lewis DJ, Miranda RN, Oh CW, Hinojosa T, Medeiros LJ, Curry JL, Tetzlaff MT, Torres-Cabala CA, Nagarajan P, Ravandi-Kashani F, Duvic M. Pruritic arthropod bite-like papules in T-cell large granular lymphocytic leukaemia and chronic myelomonocytic leukaemia. Clin Exp Dermatol 43(4):449-453, 2018. e-Pub 2018. PMID: 29423961.
Saenz-Ibarra B, Prieto VG, Torres-Cabala CA, Huen A, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Coccidioidomycosis Involving Lungs and Skin: A Mimicker of Metastatic Disease. Am J Dermatopathol 40(3):e41-e43, 2018. e-Pub 2018. PMID: 28857979.
Tetzlaff MT, Nelson KC, Diab A, Staerkel GA, Nagarajan P, Torres-Cabala CA, Chasen BA, Wargo JA, Prieto VG, Amaria RN, Curry JL. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. J Immunother Cancer 6(1):14, 2018. e-Pub 2018. PMID: 29433571.
Wilmas K, Aria A, Torres-Cabala CA, Lu H, Duvic M. Schnitzler syndrome in a patient with a family history of monoclonal gammopathy *Pathology mentor of a medical student. Dermatol Online J 24(1), 2018. e-Pub 2018. PMID: 29469761.
Jour G, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CA. Differential expression of CCR4 in primary cutaneous gamma/delta (γ/δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy (*Mentor of a Dermatopathology Fellow-Awardee of Pathology Chair's Mentored Fellow Award). J Dermatol Sci 89(1):88-91, 2018. e-Pub 2018. PMID: 29030090.
Aria AB, Chen L, Torres-Cabala CA, Chon SY. Chronic granulomatous reaction in patients receiving vaccine immunotherapy for metastatic melanoma * Pathology mentor of a medical student. JAAD Case Rep 4(1):87-90, 2018. e-Pub 2018. PMID: 29379857.
Castaneda CA, Torres-Cabala C, Castillo M, Villegas V, Casavilca S, Cano L, Sanchez J, Dunstan J, Calderon G, De La Cruz M, Cotrina JM, Gomez HL, Galvez R, Abugattas J. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America *Pathology Mentor of an international working group. Clin Transl Oncol 9(12):1478-1488, 2017. e-Pub 2017. PMID: 28577153.
Shustef E, Torres-Cabala CA, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Aung PP. Intraepithelial Melanoma in the Stomach After Treatment With Immune Checkpoint Blockade Therapy *Co-mentor of a Dermatopathology Fellow. Am J Dermatopathol 39(8):e116-e118, 2017. e-Pub 2017. PMID: 28248716.
Konopinski J, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PP. Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor. Am J Dermatopathol 39(7):545-547, 2017. e-Pub 2017. PMID: 28178009.
Valero-Torres A, Prieto VG, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall. Am J Dermatopathol 39(6):468-470, 2017. e-Pub 2017. PMID: 28525424.
Aung PP, Rady PL, Nagarajan P, Ivan D, Tetzlaff MT, Curry JL, Tyring SK, Prieto VG, Torres-Cabala CA. Detection of Merkel Cell Polyoma Virus and Beta Human Papillomavirus in Multiple Eccrine Poromas in a Patient With Acute Leukemia Treated With Stem Cell Transplant (*Mentor of a junior colleague). Am J Dermatopathol 39(6):489-491, 2017. e-Pub 2017. PMID: 27655121.
Pina-Oviedo S, Torres-Cabala CA, Miranda RN, Tetzlaff MT, Singh S, Rapini RP, Prieto VG, Aung PP. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis. Am J Dermatopathol 39(5):388-392, 2017. e-Pub 2017. PMID: 27759701.
Nagarajan P, Curry JL, Ning J, Piao J, Torres Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto V, Tetzlaff MT. Tumor thickness and mitotic rate robustly predict melanoma-specific survival in patients with primary vulvar melanoma: A retrospective review of 100 cases. Clin Cancer Res 23(8):2093-2104, 2017. e-Pub 2017. PMID: 27864417.
Agbay RL, Torres-Cabala CA, Patel KP, Merril ED, Duvic M, Quesada A, Prieto VG, Aung PP, Loghavi S, Young KH, Hu S, Ferrufino-Schmidt MC, Tetzlaff M, Li S, Medeiros LJ, Miranda RN. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens (*Co-mentor of an international visiting Pathology Fellow). Am J Surg Pathol 41(4):431-445, 2017. e-Pub 2017. PMID: 28248813.
Chakravarti N, Ivan D, Trinh VA, Glitza IC, Curry JL, Torres-Cabala C, Tetzlaff MT, Bassett RL, Prieto VG, Hwu WJ. High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients. Melanoma Res 27(1):24-31, 2017. e-Pub 2017. PMID: 27768639.
Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas (*Mentor of a medical student). Am J Surg Pathol 41(2):204-215, 2017. e-Pub 2017. PMID: 27879514.
Nicolae A, Ganapathi KA, Pham TH, Xi L, Torres-Cabala CA, Nanaji NM, Zha HD, Fan Z, Irwin S, Pittaluga S, Raffeld M, Jaffe ES. EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features. Am J Surg Pathol 41(1):67-74, 2017. e-Pub 2017. PMID: 27631517.
Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG. Clinical Significance of BRAF V600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma. Hum Pathol 59:48-54, 2017. e-Pub 2017. PMID: 27666765.
Alberti-Violetti S, Torres-Cabala CA, Talpur R, Corti L, Fanoni D, Venegoni L, Berti E, Duvic M. Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma *Pathology mentor of an international visiting Dermatology Fellow. J Cutan Pathol 43(12):1121-1130, 2016. e-Pub 2016. PMID: 27550169.
Feldmeyer L, Hudgens CW, Lyons GR, Nagarajan P, Aung PP, Curry JL, Torres Cabala CA, Mino B, Rodriguez-Canales J, Reuben A, Chen PL, Ko JS, Billings SD, Bassett RL, Wistuba II, Cooper ZA, Prieto VG, Wargo JA, Tetzlaff MT. Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma. Clin Cancer Res 15(22):5553-5563, 2016. e-Pub 2016. PMID: 27166398.
Ramani NS, Curry JL, Merrill ED, Aung PP, Prieto V, Tetzlaff MT, Duvic M, Miranda R, Torres-Cabala C. Primary Cutaneous Gamma-Delta (γ/δ) T-cell Lymphoma: An Unusual Case With Very Subtle Histopathological Findings *Mentor of a Pathology resident. Am J Dermatopathol 38(10):147-149, 2016. e-Pub 2016. PMID: 27533072.
Ravishankar S, Nagarajan P, Curry JL, Tetzlaff MT, Ivan D, Torres-Cabala CA, Aung PP, Prieto VG. Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas. J Cutan Pathol 43(8):722-724, 2016. e-Pub 2016. PMID: 27124588.
Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M. Primary cutaneous CD30(+) lymphoproliferative disorders. J Dtsch Dermatol Ges 14(8):767-82, 2016. e-Pub 2016. PMID: 27509411.
Feldmeyer L, Tetzlaff M, Fox P, Nagarajan P, Curry J, Ivan D, Torres Cabala CA, Prieto VG, Aung PP. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma. Am J Dermatopathol 38(7):484-491, 2016. e-Pub 2016. PMID: 26675354.
Al-Rohil RN, Curry JL, Torres-Cabala CA, Nagarajan P, Ivan D, Aung PP, Ray GF, Bassett RL, Prieto VG, Tetzlaff MT. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Hum Pathol 53:73-81, 2016. e-Pub 2016. PMID: 27004944.
Mudaliar K, Tetzlaff MT, Duvic M, Ciurea A, Hymes S, Milton DR, Tsai KY, Prieto VG, Torres-Cabala CA, Curry JL. BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Hum Pathol 50:79-89, 2016. e-Pub 2016. PMID: 26997441.
Danialan R, Tetzlaff MT, Torres-Cabala CA, Mays SR, Prieto VG, Bell D, Curry JL. Cutaneous metastasis from anaplastic thyroid carcinoma exhibiting exclusively a spindle cell morphology. A case report and review of literature. J Cutan Pathol 43(3):252-257, 2016. e-Pub 2016. PMID: 26347145.
Feldmeyer L, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Bell D, Moon BS, Torres-Cabala CA, Aung PP. Role of Radiotherapy in Aggressive Digital Papillary Adenocarcinoma. Ann Clin Lab Sci 46(2):222-4, 2016. e-Pub 2016. PMID: 27098633.
Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, Xu C, McKenzie JA, Zhang C, Liang X, Williams LJ, Deng W, Chen G, Mbofung R, Lazar AJ, Torres Cabala CA, Cooper ZA, Chen PL, Tieu TN, Spranger S, Yu X, Bernatchez C, Forget MA, Haymaker C, Amaria R, McQuade JL, Glitza IC, Cascone T, Li H, Kwong LN, Heffernan TP, Hu J, Bassett RL, Bosenberg MW, Woodman SE, Overwijk WW, Lizee G, Roszik J, Gajewski TF, Wargo JA, Gershenwald JE, Radvanyi LG, Davies MA, Hwu P. Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov 6(2):202-216, 2016. e-Pub 2016. PMID: 26645196.
Oh CW, Ivan D, Curry JL, Ellis R, Gerber H, Duvic M, Torres-Cabala C. A case of indeterminate dendritic cell tumor presenting with leonine facies (*Mentor of an international visitor dermatologist). J Cutan Pathol 43(2):158-163, 2016. e-Pub 2016. PMID: 26272726.
Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL. Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma. Hum Pathol 46(8):1101-10, 2015. e-Pub 2015. PMID: 26058727.
Ramani NS, Curry JL, Kapil J, Rapini RP, Tetzlaff MT, Prieto VG, Torres-Cabala CA. Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma *Mentor of a Pathology resident. Am J Dermatopathol 37(8):e96-9, 2015. e-Pub 2015. PMID: 25839886.
Wang WL, Torres-Cabala C, Curry J, Ivan D, McLemore M, Tetzlaff M, Zembowicz A, Prieto VG, Lazar AJ. Metastatic Atypical Fibroxanthoma: A Series of 11 Cases Including With Minimal and No Subcutaneous Involvement. Am J Dermatopathol 37(6):455-461, 2015. e-Pub 2015. PMID: 25590287.
Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT. Use of Clinical Next-Generation Sequencing To Identify Melanomas Harboring SMARCB1 Mutations. J Cutan Pathol 42(5):308-317, 2015. e-Pub 2015. PMID: 25754356.
de la Garza Bravo MM, Patel KP, Loghavi S, Curry JL, Torres Cabala CA, Cason RC, Gangar P, Prieto VG, Medeiros LJ, Duvic M, Tetzlaff MT. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. Hum Pathol 46(4):558-569, 2015. e-Pub 2015. PMID: 25666664.
Torres-Cabala CA, Curry JL, Li Ning Tapia EM, Ramos C, Tetzlaff MT, Prieto VG, Miranda RN, Bravo F. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci 77(3):150-155, 2015. e-Pub 2015. PMID: 25676425.
Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF(V600): Clinical Mutation Panel Testing by Next-Generation Sequencing in Advanced Melanoma. J Invest Dermatol 135(2):508-515, 2015. e-Pub 2015. PMID: 25148578.
Beltrán BE, Castillo JJ, Quiñones P, Morales D, Paredes A, Nieto G, Miranda RN, Torres-Cabala CA. Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvement *Mentor of an international junior colleague. Am J Dermatopathol 36(11):e189-93, 2014. e-Pub 2014. PMID: 25238445.
Henderson SA, Tetzlaff MT, Pattanaprichakul P, Fox P, Torres-Cabala CA, Bassett RL, Prieto VG, Richards HW, Curry JL. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma. J Cutan Pathol 41(11):846-852, 2014. e-Pub 2014. PMID: 25263506.
Loghavi S, Curry JL, Torres-Cabala CA, Ivan D, Patel KP, Mehrotra M, Bassett R, Prieto VG, Tetzlaff MT. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature. Mod Pathol 27(11):1468-78, 2014. e-Pub 2014. PMID: 24743221.
Henderson SA, Torres-Cabala CA, Curry JL, Bassett RL, Ivan D, Prieto VG, Tetzlaff MT. p40 Is More Specific Than p63 for the Distinction of Atypical Fibroxanthoma From Other Cutaneous Spindle Cell Malignancies *Co-mentor of a Dermatopathology Fellow. Am J Surg Pathol 38(8):1102-10, 2014. e-Pub 2014. PMID: 25029117.
Curry JL, Tetzlaff MT, Nicholson K, Duvic M, Kim KB, Tsai KY, Hwu WJ, Hong DS, Prieto VG, Torres-Cabala CA. Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy *Co-PI of a large series of cases from our institution. Am J Dermatopathol 36(7):557-61, 2014. e-Pub 2014. PMID: 24950418.
Kim CY, Kim DW, Kim K, Curry J, Torres-Cabala C, Patel S. GNAQ mutation in a patient with metastatic mucosal melanoma. BMC Cancer 14(1):516, 2014. e-Pub 2014. PMID: 25030020.
De la Garza Bravo MM, Curry JL, Torres-Cabala CA, Ivan DS, Drucker C, Prieto VG, Tetzlaff MT. Pigmented extramammary Paget disease of the thigh mimicking a melanocytic tumor: report of a case and review of the literature. J Cutan Pathol 41(6):529-35, 2014. e-Pub 2014. PMID: 24698435.
Le Loarer F, Barete S, Vallat L, Carre D, El Amarti R, Torres-Cabala C, Cacoub P, Sene D, Courville P, Bravard P. Primary cutaneous CD8+ T-cell lymphoma masquerading as acral vascular syndrome. Acta Derm Venereol 94(3):317-319, 2014. e-Pub 2014. PMID: 23995595.
Pattanaprichakul P, Tetzlaff MT, Lapolla WJ, Torres-Cabala CA, Duvic M, Prieto VG, Tsai KY, Curry JL. Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma. J Cutan Pathol 41(3):326-8, 2014. e-Pub 2014. PMID: 24372055.
Curry JL, Torres-Cabala CA, Kim KB, Tetzlaff MT, Duvic M, Tsai KY, Hong DS, Prieto VG. Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions. Int J Dermatol 53(3):376-84, 2014. e-Pub 2014. PMID: 23879247.
McQuitty E, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala C. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis *Mentor of a Pathology resident. First place among oral presentations at the American Society of Dermatopathology meeting, 2012. J Cutan Pathol 41(2):88-100, 2014. e-Pub 2014. PMID: 24118002.
Buonaccorsi JN, Prieto VG, Torres-Cabala C, Suster S, Plaza JA. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases. American Journal of Dermatopathology 36(2):124-30, 2014. e-Pub 2014. PMID: 23782678.
Wright NA, Torres-Cabala CA, Curry JL, Cutlan JE, Hymes SR. Post-varicella-zoster virus granulomatous dermatitis: a report of 2 cases *Pathology mentor of a medical student. Cutis 93(1):50-4, 2014. e-Pub 2014. PMID: 24505586.
Chavan RN, Bridges AG, Knudson RA, Ketterling RP, Comfere N, Wada DA, Torres-Cabala C, DiCaudo DJ, Vasmatzis G, Pittelkow MR, Feldman AL. Somatic rearrangement of the TP63 gene preceding development of mycosis fungoides with aggressive clinical course. Blood Cancer J 4:e253, 2014. e-Pub 2014. PMID: 25325303.
Tetzlaff MT, Wang WL, Milless TL, Curry JL, Torres-Cabala CA, McLemore MS, Ivan D, Bassett RL, Prieto VG. Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses. Am J Surg Pathol 37(12):1783-96, 2013. e-Pub 2013. PMID: 24061523.
Tetzlaff MT, Curry JL, Ivan D, Wang WL, Torres-Cabala CA, Bassett RL, Valencia KM, McLemore MS, Ross MI, Prieto VG. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Mod Pathol 9:1153-1160, 2013. e-Pub 2013. PMID: 23558574.
Chu VH, Tetzlaff MT, Torres-Cabala CA, Prieto VG, Bassett R, Gershenwald JE, McLemore MS, Ivan D, Wang WL, Ross MI, Curry JL. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas. Biomed Res Int 2013:898719, 2013. e-Pub 2013. PMID: 24369020.
Nava VE, Torres-Cabala C. Novel Intra-Adrenal Secondary Lymphoid Follicle Formation. Endocr Pathol 24(4):248-249, 2013. e-Pub 2013. PMID: 24014039.
Curry CV, Konoplev SN, Torres-Cabala C, Alousi A, Duvic M, Curry JL. Blastic Plasmacytoid Dendritic Cell Neoplasm with Leukemic Progress. J Med Cases 3(6):337-339, 2012. e-Pub 2012.
Curry JL, Torres-Cabala CA, Tetzlaff MT, Bowman C, Prieto VG. Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma. Semin Cutan Med Surg 31(4):267-73, 2012. e-Pub 2012. PMID: 23174497.
Curry JL, Torres-Cabala CA, Warneke CL, Zhang P, Prieto VG. Distinct Subcellular Localization of GSK-3β in Melanocytic Nevi: Implications in Melanocyte Senescence. OJ Pathology 2:113-119, 2012. e-Pub 2012.
Rose CL, Chakravarti N, Curry JL, Torres-Cabala CA, Bassett R, Prieto VG, Tetzlaff MT. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms. J Cutan Pathol 39(8):762-8, 2012. e-Pub 2012. PMID: 22764884.
Shirley SH, Greene VR, Duncan LM, Torres Cabala CA, Grimm EA, Kusewitt DF. Slug Expression during Melanoma Progression. Am J Pathol 180(6):2479-89, 2012. e-Pub 2012. PMID: 22503751.
Zhang YH, Wang WL, Rapini RP, Torres-Cabala C, Prieto VG, Curry JL. Syringocystadenocarcinoma Papilliferum With Transition to Areas of Squamous Differentiation: A Case Report and Review of the Literature. American Journal of Dermatopathology 34(4):428-33, 2012. e-Pub 2012. PMID: 22343110.
McLemore MS, Bruner JM, Curry JL, Prieto VG, Torres-Cabala CA. Anaplastic oligodendroglioma involving the subcutaneous tissue of the scalp: report of an exceptional case and review of the literature *Mentor of a junior colleague. Am J Dermatopathol 34(2):214-9, 2012. e-Pub 2012. PMID: 22157246.
Martinez DR, Richards HW, Lin Q, Torres-Cabala CA, Prieto VG, Curry JL, Medrano EE. H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma. J Skin Cancer 2012:823534, 2012. e-Pub 2012. PMID: 23227340.
Béjar C, Vidarte G, Chian C, Valencia J, Torres-Cabala C. Nodular syphilis spread associated with HIV/AIDS prozone phenomenon *Mentor of an international Dermatology resident. Dermatol Peru 23(3):162-165, 2012. e-Pub 2012.
McLemore MS, Huo L, Deavers MT, Curry JL, Torres-Cabala CA, Wang WL, Prieto VG. Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall. J Cutan Pathol 38(10):818-22, 2011. e-Pub 2011. PMID: 21752053.
Savar A, Oellers P, Myers J, Prieto VG, Torres-Cabala C, Frank SJ, Ivan D, Esmaeli B. Positive Sentinel Node in Sebaceous Carcinoma of the Eyelid. Ophthal Plast Reconstr Surg 27(1):e4-6, 2011. e-Pub 2011. PMID: 20940661.
Torres-Cabala CA, Plaza JA, Diwan AH, Prieto VG. Severe architectural disorder is a potential pitfall in the diagnosis of small melanocytic lesions. J Cutan Pathol 37(8):860-5, 2010. e-Pub 2010. PMID: 19614731.
Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 22(11):1446-56, 2009. e-Pub 2009. PMID: 19718013.
Plaza JA, Torres-Cabala C, Evans H, Diwan AH, Prieto VG. Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases. Am J Dermatopathol 31(5):419-22, 2009. e-Pub 2009. PMID: 19542912.
Plaza JA, Torres-Cabala C, Ivan D, Prieto VG. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy. J Cutan Pathol 36(7):729-33, 2009. e-Pub 2009. PMID: 19519604.
Shanti RM, Torres-Cabala CA, Jaffe ES, Wilson WH, Brahim JS. Lymphomatoid granulomatosis with involvement of the hard palate: a case report. J Oral Maxillofac Surg 66(10):2161-3, 2008. e-Pub 2008. PMID: 18848119.
Merino MJ, Torres-Cabala C, Pinto P, Linehan WM. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31(10):1578-85, 2007. e-Pub 2007. PMID: 17895761.
Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177(6):2074-9, 2007. e-Pub 2007. PMID: 17509289.
Torres-Cabala C, Bibbo M, Panizo-Santos A, Barazi H, Krutzsch H, Roberts DD, Merino MJ. Proteomic identification of new biomarkers and application in thyroid cytology. Acta Cytol 50(5):518-528, 2006. e-Pub 2006. PMID: 17017437.
Kim CM, Vocke C, Torres-Cabala C, Yang Y, Schmidt L, Walther M, Linehan WM. Expression of hypoxia inducible factor-lalpha and 2alpha in genetically distinct early renal cortical tumors. J Urol 175(5):1908-14, 2006. e-Pub 2006. PMID: 16600797.
Li-Ning-T E, Ronchetti R, Torres-Cabala C, Merino MJ. Role of chomogenic in Situ Hybridization (CISH TM) in the Evaluation of HER2 status in breast carcinoma. Int J Surg Pathol 13(4):343-51, 2005. e-Pub 2005. PMID: 16273190.
Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, Neckers L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8(2):143-53, 2005. e-Pub 2005. PMID: 16098467.
Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM. High frequency of somatic frameshift BHD mutations in Birt-Hogg-Dube-associated renal tumors. J Natl Cancer Inst 97(12):931-5, 2005. e-Pub 2005. PMID: 15956655.
Pavlovich CP, Grubb RL, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM. Evaluation and management of renal tumors in the Birt-Hogg-Dube syndrome. J Urol 173(5):1482-6, 2005. e-Pub 2005. PMID: 15821464.
Alleman WG, Tabios RL, Chandramouli GV, Aprelikova ON, Torres-Cabala C, Mendoza A, Rogers C, Rodgers C, Sopko NA, Linehan WM, Vasselli JR. The in vitro and in vivo effects of re-expressing methylated von Hippel-Lindau tumor suppressor gene in clear cell renal carcinoma with 5-aza-2'-deoxycytidine. Clin Cancer Res 10(20):7011-21, 2004. e-Pub 2004. PMID: 15501981.
Schmidt LS, Nickerson ML, Angeloni D, Glenn GM, Walther MM, Albert PS, Warren MB, Choyke PL, Torres-Cabala CA, Merino MJ, Brunet J, Bérez V, Borràs J, Sesia G, Middelton L, Phillips JL, Stolle C, Zbar B, Pautler SE, Linehan WM. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyroisine kinase domain of the Met proto-oncogene. J Urol 172(4 Pt 1):1256-1261, 2004. e-Pub 2004. PMID: 15371818.
Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS. Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissues. Mod Pathol 17(8):998-1011, 2004. e-Pub 2004. PMID: 15143337.
Torres-Cabala C, Panizo-Santos A, Krutzsch HC, Barazi H, Namba M, Sakaguchi M, Roberts DD, Merino MJ. Differential expression of S100C in thyroid lesions. Int J Surg Pathol 12(2):107-115, 2004. e-Pub 2004. PMID: 15173915.
Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, Worrell R, Torres-Cabala C, Tabios R, Mariotti A, Stearman R, Merino M, Walther MM, Simon R, Klausner RD, Linehan WM. Predicting survival in patients with metastatic kidney cancer by gene expression profiling in the primary tumor. Proc Natl Acad Sci U S A 100(12):6958-63, 2003. e-Pub 2003. PMID: 12777628.

Invited Articles

Curry JL, Falchook GS, Torres-Cabala CA, Tetzlaff MT, Prieto VG. Resistant mechanisms to BRAF inhibitor PLX4032 in melanoma. Expert Review of Dermatology 6(4):355-357, 2011. e-Pub 2011.

Manuals, Teaching Aids, Other Teaching Publications

Torres-Cabala CA, Linehan WM, Merino MJ. Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions. Surgical Pathology II Check Sample Exercise. ASCP, 2005.

Editorials

Giubellino A, Torres-Cabala CA. Editorial for Special Issue "Molecular Mechanisms and Signaling Pathways in Melanoma". Cancers (Basel) 15(19):4675, 2023. PMID: 37835369.

Abstracts

Torres-Cabala CA, Jaffe ES, Pittaluga S, Raffeld M, Salomon M, Bravo FG. Hydroa vacciniforme-like EBV-associated lymphoprolifeative disorder: report of a case with evidence of progression. Am J Dermatopath 29(2):204, 2007. e-Pub 2007.
Torres-Cabala CA, DeWitt CA, Stabinski L, DeCastro R, Holland S, Turner ML, Lee CR. Acquired acrodermatitis enteropathica in a patient with multiple nutrient deficiencies after gastric bypass. Am J Dermatopath 29(2):205, 2007. e-Pub 2007.
Kim, CM, Vocke K, Torres-Cabala C, Yang YF, Walther MM, Linehan WM. Expression of hypoxia inducible factors in genetically distinct early renal cortical tumors. J Urol 173(4):95, 2005. e-Pub 2005.
Isaacs JS, Jung YJ, Mole D, Lee S, Torres-Cabala CA, Marino M, Trepel J, Zbar B, Toro J, Ratcliffe P, Linehan M, Neckers L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability. Proc Amer Assoc Cancer Res 46:610, 2005. e-Pub 2005.
Wei M, Torres-Cabala C, Nickerson M, Glenn G, Turner M, Linehan WM, Merino M, Schmidt L, Zbar B, Toro JR. Mutations in the fumarate hydratase causes hereditary leiomyomatosis and renal cell carcinoma in families in North America. Proc Amer Assoc Cancer Res 45:524, 2004. e-Pub 2004.
Torres-Cabala CA, Wrathall LS, Ronchetti RD, Chian CA, Sobel M, Linehan WM, Merino MJ. Molecular and cytogenetic profile of type 1 papillary renal cell carcinoma with clear cell differentiation: concurrence or tumor progression?. Mod Pathol 17:180A, 2004. e-Pub 2004.
Chian-Garcia CA, Torres-Cabala CA, Lozano Z, Wrathall LS, Merino MJ. Loss of heterozygosity of chromosome 9p21 and expression of p16 protein in acral melanomas. Mod Pathol 17:91A, 2004. e-Pub 2004.
Mosquera JM, Torres-Cabala C, Chian-Garcia C, Otis C, Roberts D, Merino MJ. Identification of new markers in ovarian cancer with ptoential use in diagnosis and treatment. Mod Pathol 17:208A, 2004. e-Pub 2004.
Chian-Garcia CA, Torres-Cabala CA, Otis C, Barazi H, Roberts DD, Merino MJ. The search for new potential markers in ovarian carcinoma through proteomic analysis. Mod Pathol 17:193A, 2004. e-Pub 2004.
Ronchetti RD, Torres-Cabala CA, Chian-Garcia CA, Duray PH, Philips J, Linehan WM. Expression of estrogen receptor alpha and beta, androgen receptor, and glutathione-s-transferase π in prostatic adenocarcinoma. Mod Pathol 16(1):167A, 2003. e-Pub 2003.
Merino MJ, Torres-Cabala CA, Zbar B, Chian-Garcia C, Lineham WM. Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC): clinical histopathological and molecular features of the first American families described. Mod Pathol 16(1):162A, 2003. e-Pub 2003.
Torres-Cabala CA, Worrell RA, Chian-Garcia CA, Martinez A, Merino MJ, Linehan WM. Immunohistochemical expression of hypoxia-induced mediators and correlation with VHL gene mutation in sporadic clear cell renal carcinoma. Mod Pathol 16(1):173A, 2003. e-Pub 2003.
Ronchetti RD, Torres-Cabala CA, Chian-Garcia CA, Eyler R, Linehan WM, Merino MJ. Detection of chromosome 7 and 17 aneuploidy in type 1 papillary renal cell carcinoma by chromogenic in situ hybridization (CISH). A comparison with other renal cell tumors. Mod Pathol 16(1):167A, 2003. e-Pub 2003.
Chian-Garcia CA, Torres-Cabala CA, Eyler R, Linehan WM, Merino MJ. Renal cell carcinoma in children and young adults: A clinicopathological and immunohistochemical study of 14 cases. Mod Pathol 16(1):145A, 2003. e-Pub 2003.
Chian CA, Torres CA, Ronchetti RD, Linehan WM, Merino MJ. Immunohistochemical profile of Aquaporin-1, Tamm-Horsfall protein, and chloride channel-2 in subtypes of renal cell carcinoma. Proc Amer Assoc of Cancer Res 44:1243, 2003. e-Pub 2003.
Bravo F, Torres-Cabala C, Munoz S. The spectrum of palisaded granulomas and "necrobiosis" in patients with arthritis. Am J Dermatopath 21(1):75, 1999. e-Pub 1999.

Book Chapters

Evans M, Torres-Cabala CA. Molecular Landscape of Cutaneous T-cell Lymphoma Variants. In: Advances in Molecular Pathology. Elsevier, 2022.
Danialan R, Torres-Cabala CA. Cutaneous Manifestations of Myeloproliferative Neoplasms. In: Hematopathology of the Skin. Wolters Kluwer, 537-549, 2022.
Torres Cabala, CA, Tetzlaff, M, Nagarajan, P, Ivan, D, Curry, JL, Aung, PP, Prieto, V. Skin, 3-227, 2020.
Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Ivan D, Curry JL, Aung PP, Prieto VG. Skin. In: Oncological Surgical Pathology. Springer, 2020.
Torres-Cabala CA, Modi MB, Junkins-Hopkins JM. T cell disorders. In: Dermatopathology for Residents, 2019.
Berti E, Willemze R, Guitart J, Jaffe ES, Kempf W, Petrella T, Robson A, Cerroni L, Torres-Cabala CA. Primary cutaneous peripheral T-cell lymphomas, rare subtypes. In: WHO Classification of Skin Tumors. IARC Press, 2018.
Castaneda Altamirano CA, Rebaza Vasquez LP, Torres-Cabala CA. Skin Cancer: Melanoma. In: Medical Oncology. 2nd. Universidad de San Martin de Porres, 2018.
Danialan R, Torres-Cabala CA. Cutaneous Manifestations of Myeloproliferative Neoplasms. In: Hematopathology of the Skin. Wolters Kluwer, 537-549, 2017.
Curry, JL, Tetzlaff, M, Nagarajan, P, Torres Cabala, CA. Immunohistology of melanocytic lesions, 311-334, 2016.
Torres Cabala, CA, Aung, PP, Miranda, R, Curry, JL. Immunohistology and molecular studies of cutaneous t-cell lymphomas and mimics, 229-259, 2016.
Curry JL, Tetzlaff MT, Nagarajan P, Torres-Cabala CA. Immunohistology of Melanocytic Lesions. In: Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. Springer International, 311-334, 2016.
Curry JL, Ciurea AM, Nagarajan P, Torres-Cabala CA. Dermatologic toxicities to Melanoma Targeted Therapies. In: Genetics in Melanoma. Springer, 267-277, 2016.
Torres-Cabala CA, Aung P, Miranda RN, Curry JL. Immunohistology and Molecular Studies of Cutaneous T-Cell Lymphomas and Mimics. In: Applied Immunohistochemistry in the Evaluation of Skin Neoplasms. Springer International, 229-259, 2016.
Torres-Cabala CA, Tetzlaff MT, Curry JL. Biomarker Analysis of Gene-Mutated Protein Products by Immunohistochemistry in Melanoma. In: Genetics of Melanoma. Springer, 181-191, 2016.
Torres-Cabala CA, Curry JL, Chenn SS, Miranda RN. Hematolymphoid Proliferations of the Skin. In: Precision Molecular Pathology of Dermatologic Diseases. Springer Science, 2015.
Torres-Cabala CA, Mutyambizi K, Bravo F. Infectious Diseases of the Skin. In: Precision Molecular Pathology of Dermatologic Diseases. Springer Science, 2015.
Curry JL, Torres-Cabala C, Prieto VG. Histopathology of Nonmelanoma Skin Cancer. In: Cutaneous Malignancy of the Head and Neck: A multidisciplinary approach. 1st. Plural Publishing Inc, 2011.
Li-Ning E, Torres-Cabala C. Dysplastic Nevus Syndrome. In: Encyclopedia of Pathology. 1st. Springer-Verlag, 2009.
Quezado M, Torres-Cabala CA, Berman D. Molecular Pathology in Life-Cycle Management in Drug Development. In: Molecular Pathology in Drug Discovery and Development. 1st. John Wiley & Sons, 169-185, 2009.
Merino MJ, Torres-Cabala CA. Pathology of Inherited Forms of Renal Carcinoma. In: Comprehensive Textbook of Genitourinary Oncology. 3rd. Lippincott Williams and Wilkins, 697-700, 2006.
Pulitzer M, Kempf W, Guitart J, Torres-Cabala CA, Willemze R. Primary cutaneous gd T Cell lymphoma. In: WHO Classification of Skin Tumors. IARC Press.
Torres-Cabala, CA Moran CA, C Kalhor N, Weissferdt A. Hematolymphoid neoplasms of the skin. In: Oncological Surgical Pathology Practice at MD Anderson Cancer Center. Springer International Publishing.

Books (edited and written)

Torres-Cabala CA, Curry JL. Genetics of Melanoma. Springer, 2016.

Letters to the Editor

Guitart J, Chung C, Torres-Cabala CA. The dilemma of primary γδ epidermotropic T-cell lymphoma: Distinction from mycosis fungoides signs of cytotoxicity and need for more detailed analysis. Journal of Cutaneous Pathology, 2022.
Plaza JA, Torres-Cabala CA, Ivan D, Prieto VG. Reply. J Cutan Pathol 37: 916, 2010.

Less

Selected Presentations & Talks

Local Presentations

2022. The Art and Science of Managing the New Melanoma Landscape. Conference. The Art and Science of Managing the New Melanoma Landscape. Houston, TX, US.
2020. The Art and Science of Managing the New Melanoma Landscape. Conference. The Art and Science of Managing the New Melanoma Landscape. Houston, TX, US.
2020. The Art and Science of Managing the New Melanoma Landscape. Conference. The Art and Science of Managing the New Melanoma Landscape. Houston, TX, US.
2016. The Art and Science of Managing the New Melanoma Landscape. Conference. The Art and Science of Managing the New Melanoma Landscape. Houston, TX, US.
2016. Tumor Board & Case Presentation, Medical Education Program on Melanoma Management. Conference. Tumor Board & Case Presentation, Medical Education Program on Melanoma Management. Houston, TX, US.
2016. Acral lentiginous melanoma. Conference. Acral lentiginous melanoma. Houston, TX, US.
2013. Melanoma Medical Oncology: Tumor Board on Melanoma. Conference. Melanoma Medical Oncology: Tumor Board on Melanoma. Houston, TX, US.
2010. Correlation between immunohistochemical expression of KIT and KIT mutation in acral lentiginous melanoma. Conference. Correlation between immunohistochemical expression of KIT and KIT mutation in acral lentiginous melanoma. Houston, TX, US.

National Presentations

2024. Pitfalls in the evaluation of melannocytic neoplasms. Pitfalls in Dermatopathology/Stump the Champs/Chumps. San Diego, CA, US.
2023. Advanced Melanoma: The Evolving Role of Biomarker Testing in Treatment and Prognosis, Harnessing Pathological Response and Biomarker Testing to Improve Patient Care in NSCLC and Melanoma (ACTIVATE) course. Conference. Advanced Melanoma: The Evolving Role of Biomarker Testing in Treatment and Prognosis, Harnessing Pathological Response and Biomarker Testing to Improve Patient Care in NSCLC and Melanoma (ACTIVATE) course. Houston, TX, US.
2023. T-cell, Primary Cutaneous B cell Lymphomas Guidelines Panel Meeting. Conference. National Comprehensive Cancer Network (NCCN). Plymouth, PA, US.
2023. New molecular tools in Dermatopathology. Conference. Oncologic Dermatology Update Course. Houston, TX, US.
2023. Update in primary cutaneous T cell lymphoid proliferations. Conference. Oncologic Dermatology Update Course. Houston, TX, US.
2023. Melanoma: advances in diagnosis, prognosis, and predictive biomarkers. Conference. Oncologic Surgical Pathology course "Dr. Hector Santiago Payan". Mexico, US.
2022. Melanoma: Update on diagnosis, prognostic and predictive criteria-Virtual Conference. Conference. Melanoma: Update on diagnosis, prognostic and predictive criteria-Virtual Conference. Houston, TX, US.
2022. Neoplastic extramedullary hematopoiesis in a patient with chronic myeloid leukemia. Learning from the Experts. Conference. Neoplastic extramedullary hematopoiesis in a patient with chronic myeloid leukemia. Learning from the Experts. New York, NY, US.
2022. The differential diagnosis of predominantly epidermotropic gamma/delta T cell lymphoma: a clinicopathological dilemma. Dermatopathology Evening Session. Conference. The differential diagnosis of predominantly epidermotropic gamma/delta T cell lymphoma: a clinicopathological dilemma. Dermatopathology Evening Session. Los Angeles, CA, US.
2022. Epidermotropic gamma/delta T cell lymphoma: molecular landscape. Conference. Epidermotropic gamma/delta T cell lymphoma: molecular landscape. Los Angeles, CA, US.
2021. Gamma-delta phenotype in primary cutaneous T cell lymphoid proliferations: a clinico-pathological dilemma. Conference. Division of Pathology and Laboratory Medicine Grand Rounds. Houston, TX, US.
2021. TERT status in acral lentiginous melanoma. Conference. The Society for Melanoma Research Congress-Virtual Meeting. New Orleans, LA, US.
2021. The pathology report of melanoma. Advanced Dermatopathology Course. Conference. The pathology report of melanoma. Advanced Dermatopathology Course, US.
2021. Acral Melanoma: New Insights. Conference. V International Symposium of Lymphomas & Melanomas. Webinar, US.
2021. My professional journey. Conference. The University of Texas MD Anderson Cancer Center, Division of Pathology and Laboratory Medicine. Houston, TX, US.
2020. Melanoma Discipline Breakout Session-Zoom. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2020. Partner/Associate Roundtable-Zoom. Conference. The University of MD Anderson Cancer Center. Houston, TX, US.
2020. Melanoma Multidisciplinary Care Discussion Panel-Zoom. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2020. Hematolymphoid of the skin: educational cases. Conference. Latin and Iberoamerican Society of Dermatopathology. Houston, TX, US.
2020. Update on Role of Immunohistochemistry in the Evaluation of Lymphoid Proliferations in the Skin. Conference. IberoLatinAmerican Society of Dermatopathology, US.
2019. Navigating cutaneous lymphomas: Intergrating clinical, histopathological, and molecular findings in the daily practice. Conference. Navigating cutaneous lymphomas: Intergrating clinical, histopathological, and molecular findings in the daily practice. Minneapolis, MN, US.
2019. Sarcoma & Melanoma Oncology Integration Retreat. Pathology overview and discussion of cases. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
2019. Workshop on subcutaneous panniculitis-like T-cell lymphomas. Conference. Workshop on subcutaneous panniculitis-like T-cell lymphomas. Chicago, IL, US.
2019. National Comprehensive Cancer Network (NCCN) T-cell. Conference. National Comprehensive Cancer Network (NCCN) T-cell. Plymouth, PA, US.
2019. Workshop on subcutaneous panniculitis-like T-cell lymphomas. Conference. Workshop on subcutaneous panniculitis-like T-cell lymphomas. Chicago, IL, US.
2019. Challenges in the diagnosis of cutaneous T-cell lymphomas: putting all the pieces together. Long course, Common problems in Dermatopathology: a survival guide for the practicing pathologist. Conference. United States and Canadian Academy of Pathology Annual Meeting. National Harbor, MD, US.
2019. Workshop on non-MF cutaneous T cell lymphomas. Conference. Workshop on non-MF cutaneous T cell lymphomas. Washington, DC, US.
2018. Mature B-cell Neoplasia. Short Course on B-cell lymphomas and lymphoproliferative disorders. Conference. The American Society of Dermatopathology. Chicago, IL, US.
2018. National Comprehensive Cancer Network (NCCN) T-cell. Conference. National Comprehensive Cancer Network (NCCN) T-cell. Philadelphia, PA, US.
2018. Myeloid neoplasms involving skin. Conference. 59th Annual Spring Symposium-Dermatopathology. Houston, TX, US.
2018. Atypical vascular lesions of the skin. Conference. Diagnostic Pathology Course. Houston, TX, US.
2017. BAP1-deficient melanocytic nevus, Self-Assessment Course. Conference. XXXVIII Symposium of the International Society of Dermatopathology. Glasgow.
2016. Primary cutaneous follicle center lymphoma with increased proliferation rate: a pitfall. Conference. Primary cutaneous follicle center lymphoma with increased proliferation rate: a pitfall. Chicago, IL, US.
2016. Primary cutaneous marginal zone lymphoma with expression of lgG4. Conference. Primary cutaneous marginal zone lymphoma with expression of lgG4. Chicago, IL, US.
2016. Angiomatoid melanoma: a tumor with vasculogenic mimicry. Conference. Angiomatoid melanoma: a tumor with vasculogenic mimicry. Chicago, IL, US.
2016. Primary Cutaneous Gamma-Delta T-Cell Lymphomas Do Not Display TH2 Chemokine Expression: Significance For Diagnosis and Therapy. Conference. Primary Cutaneous Gamma-Delta T-Cell Lymphomas Do Not Display TH2 Chemokine Expression: Significance For Diagnosis and Therapy. Arlington, VA, US.
2015. Update in the diagnosis of melanoma. Conference. Mexican Academy of Dermatology. Mexico City, Mexico, US.
2015. Cutaneous lymphomas: a practical approach. Conference. Mexican Academy of Dermatology. Mexico City, Mexico, US.
2015. Cutaneous aggressive NK leukemia/lymphoma, EBV negative. Conference. Dermatopathology Specialty Course. Boston, MA, US.
2015. Primary cutaneous gamma/delta T cell lymphoma. Conference. Dermatopathology Specialty Conference. Boston, MA, US.
2015. Drug triggered cutaneous neoplasia. Course: "New patterns of cutaneous adverse drug reactions". Conference. Drug triggered cutaneous neoplasia. Course: "New patterns of cutaneous adverse drug reactions". San Francisco, CA, US.
2015. Acral-lentiginous melanoma: MDACC clinical, histological and molecular experience. Conference. Diagnostic Pathology Course. Houston, TX, US.
2012. Self-Assessment Course/BRAF-inhibitor associated panniculitis. Conference. The International Society of Dermatopathology (ISDP). San Diego, CA, US.
2012. Self-Assessment Course/Mantle cell lymphoma involving skin. Conference. The International Society of Dermatopathology (ISDP). San Diego, CA, US.
2012. Self-Assessment Course/Lymphomatoid papulosis type D. Conference. The International Society of Dermatopathology (ISDP). San Diego, CA, US.
2011. Hydroa vacciniforme-like T cell lymphoma. Conference. Society of Hematopathology and European Association of Haematopathology (SH/EAHP). Los Angeles, CA, US.
2011. CD8-positive lymphomatoid papulosis ("type D"). Conference. Society of Hematopathology and European Association of Haematopathology (SH/EAHP). Los Angeles, CA, US.
2011. HTLV-1-associated infective dermatitis. Conference. Society of Hematopathology and European Association of Haematopathology (SH/EAHP). Los Angeles, CA, US.
2011. Update in melanocytic lesions of the skin. Conference. Division of Daegu-Kyungbook, Korean Society of Pathologists, The University of Texas MD Anderson Cancer Center. Daegu.
2009. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral lentiginous/mucosal type (Platform Presentation). Conference. The American Society of Dermatopathology. Chicago, IL, US.
2007. Acquired acrodermatitis enteropathica in a patient with multiple nutrient deficiencies after gastric bypass (Platform Presentation). Conference. The International Society of Dermatopathology. Washington, DC, US.
2007. Hydroa vacciniforme-like EBV-associated lymphoproliferative disorder: report of a case with evidence of progression (Platform Presentation). Conference. The International Society of Dermatopathology. Washington, DC, US.
2006. Are some collecting duct carcinomas indeed HLRCC tumors? (Platform Presentation). Conference. The United States and Canadian Academy of Pathology. Atlanta, GA, US.
2003. Histopathological and molecular features of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC) syndrome-associated kidney tumors (Platform Presentation). Conference. American Association for Cancer Research. Washington, DC, US.

International Presentations

2024. Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphoma with FGFR1 fusion. Dermatopathology Slide Seminar. Invited. Cancun, MX.
2024. Primary cutaneous cytotoxic T-cell lymphomas: pitfalls and contributions. Invited. Cancun, MX.
2024. Metastatic melanoma biomakers: PD-L1/SOX10 and apoptosis-pathway molecules expression, significance for prognosis and therapy. Invited. 17th International Melanoma Pathology Symposium of the International Melanoma Pathology Study Group. New Orleans, US.
2024. Histopathological diagnosis of primary cutaneous B-cell lymphomas/lymphoid proliferations. Invited. International Course of Dermatopathology. Arequipa, PE.
2024. Tests of clinical utility in the diagnosis and management of melanoma. Invited. XLI RADLA (Annual Meeting of Latin American Dermatologists). Lima, PE.
2024. Clinicopathological approach in the diagnosis of cutaneous lymphoma, Plenary session. Invited. XLI RADLA (Annual Meeting of Latin American Dermatologists). Lima, PE.
2024. Importance of clinico-pathological correlation and histopathological clues in the diagnosis of challenges melanocytic lesions. Invited. XXV Peruvian Congress of the Peruvian Association of Pathologists. Lima, PE.
2023. The thousand and one faces of primary cutaneous CD30-positive T cell lymphoproliferative disorders. Invited. XXXIV Meeting of the Latin American Society of Pathology. Buenos Aires, AR.
2023. Defenses Down: Understanding Cutaneous Pathology in the Immunocompromised. Invited. 5th DIAD-DIAL Conference and XLII Symposium of the ISDP. Dubai, AE.
2023. Lymphoma's Uncharted Territories: Insights into Primary Cytotoxic CTCL. Invited. 5th DIAD-DIAL Conference and XLII Symposium of the ISDP. Dubia, AE.
2023. Update in cutaneous lymphomas. Conference. V International Congress of Dermatopathology Refuerza, School of Medicine. Mexico City, MX.
2023. Primary cutaneous cytotoxic T cell lymphomas. Conference. V International Congress of Dermatopathology Refuerza, School of Medicine. Mexico City, MX.
2023. Primary cutaneous Diffuse Large B cell lymphoma, leg type, with spontaneous regression. Conference. V Symposium of Gell. Cusco, PE.
2023. What is new in primary cutaneous lymphomas?. Conference. What is new in primary cutaneous lymphomas?. Curitiba, BR.
2023. Primary cutaneous CD8-positive aggressive epidermotropic T cell lymphoma in a child. Conference. Dermatology Sister Societies Symposium. Curitiba, BR.
2022. Primary cutaneous gamma delta T cell lymphoma. Conference. II Clinical Symposium-Virtual. Cali, CO.
2022. Advances in the pathological diagnosis of melanoma. Conference. Advances in the pathological diagnosis of melanoma. Lima, PE.
2022. International League of Dermatology Societies. Conference. Third World Skin Summit, International Society of Dermatopathology delegate. Lima, PE.
2022. Primary cutaneous gamma/delta T-Cell lymphoma: Clinical and pathological characteristics. Conference. Medical Oncology Medical Association. Lima, PE.
2022. Primary cutaneous EBV-positive diffuse large B cell lymphoma. The best of ASH 2011-Virtual Meeting. Conference. Primary cutaneous EBV-positive diffuse large B cell lymphoma. The best of ASH 2011-Virtual Meeting. Lima, PE.
2021. How I approach the differential diagnosis between cutaneous lymphomas and inflammatory dermatoses. Conference. How I approach the differential diagnosis between cutaneous lymphomas and inflammatory dermatoses. Lima, PE.
2021. Biomarkers in Melanoma. Conference. Biomarkers in Melanoma. Lima, PE.
2021. What is new in cutaneous T cell lymphomas. Conference. What is new in cutaneous T cell lymphomas, CR.
2021. Acral lentiginous melanoma: New insights. Conference. Acral lentiginous melanoma: New insights. London, GB.
2021. Myeloid proliferations in the skin. Conference. Myeloid proliferations in the skin. London, GB.
2021. Pathology of T-Cell lymphoproliferative disorders in the skin. Conference. Pathology of T-Cell lymphoproliferative disorders in the skin. IREN Centro, PE.
2021. The pathologist role in the diagnosis, prognosis, and therapy of melanoma. Conference. The pathologist role in the diagnosis, prognosis, and therapy of melanoma. Lima, PE.
2020. Granulomatous Mycosis Fungoides: a Clinicopathological Study of 40 cases from a Tertiary Cancer Center. Conference. Granulomatous Mycosis Fungoides: a Clinicopathological Study of 40 cases from a Tertiary Cancer Center. Barcelona, ES.
2019. Interesting cases from MD Anderson Cancer Center. Conference. British Society of Dermatopathology. Leeds, GB.
2019. My approach to Hematolymphoid Disorders of the Skin: B cell lymphomas. Conference. Latin American Society of Pathology. Lima, PE.
2019. Leukemia Cutis. Conference. Leukemia Cutis. Lima, PE.
2019. Neuroendocrine Tumors of the Skin: an Update. Conference. Neuroendocrine Tumors of the Skin: an Update. Lima, PE.
2019. Workshop on Folliculotropic Mycosis Fungoides. Conference. Workshop on Folliculotropic Mycosis Fungoides. Milan, IT.
2019. A young patient presenting with bilateral caruncle masses. Conference. International League of Dermatologic Societies (ILDS), Sister Society Meeting. Milan, IT.
2019. What is new in cutaneous T cell lymphomas?. Conference. What is new in cutaneous T cell lymphomas?. Fortaleza, BR.
2019. Cutaneous B cell lymphomas. Conference. Cutaneous B cell lymphomas. Fortaleza, BR.
2019. Selected hematolymphoid lesions of the skin. Conference. Lisbon Pathology Update. Lisbon, PT.
2019. Biomarkers and ancillary tests in melanocytic lesions. Conference. Lisbon Pathology Update. Lisbon, PT.
2019. Update in cutaneous T-cell lymphomas. Conference. MD Anderson Cancer Center and Mexican Institute of Social Security. Mexico City, MX.
2019. Leukemia cutis. Conference. MD Anderson Cancer Center and Mexican Institute of Social Security. Mexico City, MX.
2018. Dermatopathology: Melanoma in 2018. Conference. Dermatopathology: Melanoma in 2018. San Salvador, SV.
2018. T-cell lymphomas. Conference. T-cell lymphomas. Sao Paulo, BR.
2018. Pathology of Melanoma. Conference. Universidad Nacional de San Agustin Medical School. Arequipa, PE.
2018. Update in melanoma: From histopathology to molecular tests. Conference. Update in melanoma: From histopathology to molecular tests. Qingdao, CN.
2018. Neuroendocrine Tumors of the Skin. Conference. "Dr. Hector Santiago Payan Oncologic Surgical Pathology Course". Mexico City, MX.
2018. Melanoma biomarkers: application in diagnosis and therapy. Conference. "Dr. Hector Santiago Payan Oncologic Surgical Pathology Course.". Mexico City, MX.
2018. Biomarkers in melanoma. Conference. IV International MD Anderson-Guatemalan Society of Clinical and Anatomic Pathology. Antigua, GT.
2017. How to select ancillary tests for diagnosis in Dermatopathology. Conference. Argentinian Society of Pathology. Cordoba, AR.
2017. Update in melanoma: surgical and molecular pathology for the general pathologist. Conference. Argentinian Society of Pathology. Cordoba, AR.
2017. Molecular Pathology of Melanoma: from FISH to Immunotherapy. Conference. UT MD Anderson Cancer Center and Rigshospitalet Copenhagen University Hospital. Copenhagen, DK.
2017. Update in Cutaneous Lymphomas. Conference. UT MD Anderson Cancer Center and Rigshospitalet Copenhagen University Hospital. Copenhagen, DK.
2017. Translational research in melanoma: an overview. Conference. Translational research in melanoma: an overview. Arequipa, PE.
2017. Update in Cutaneous Lymphomas. Conference. "Dr. Hector Santiago Payan Oncologic Surgical Pathology Course". Mexico City, MX.
2017. Ancillary tests in Dermatopathology: what is new in epithelial, vascular, and melanocytic lesions. Conference. "Dr. Hector Santiago Payan Oncologic Surgical Pathology Course". Mexico City, MX.
2016. Ancillary tests in Dermatopathology. Conference. XXIII Congress of the Peruvian Association of Pathologists. Arequipa, PE.
2016. Primary cutaneous lymphomas: what is new in the 2016 revision of the WHO classification. Conference. Primary cutaneous lymphomas: what is new in the 2016 revision of the WHO classification. Arequipa, PE.
2016. Primary cutaneous T cell lymphomas with gamma/delta phenotype. Conference. Primary cutaneous T cell lymphomas with gamma/delta phenotype. Lima, PE.
2016. Update in the diagnosis of melanoma and the increasing role of molecular testing (Teleconference). Conference. MD Anderson and Griffith University. Gold Coast, AU.
2016. Update of the WHO classification of cutaneous lymphomas (2016 revision). Conference. Update of the WHO classification of cutaneous lymphomas (2016 revision). Lima, PE.
2016. What is new in the diagnosis of melanoma. Conference. What is new in the diagnosis of melanoma. Lima, PE.
2016. Ancillary tests in dermatopathology. Conference. Ancillary tests in dermatopathology. Antigua, GT.
2016. The pathologist's role in the management of patients with skin tumors. Conference. The pathologist's role in the management of patients with skin tumors. Antigua, GT.
2016. Update in cutaneous T cell lymphomas. Conference. MD Anderson & Edgardo Rebagliati Hospital. Cusco, PE.
2016. Update in cutaneous B cell lymphomas. Conference. MD Anderson & Edgardo Rebagliati Hospital. Cusco, PE.
2015. Genetics of acral lentiginous melanoma. Conference. Genetics of acral lentiginous melanoma. New Delhi, IN.
2015. Primary cutaneous epidermotropic B cell lymphoma. Conference. Primary cutaneous epidermotropic B cell lymphoma. Santa Cruz, BO.
2015. A survival manual for the general pathologist: Cutaneous lymphomas. Conference. A survival manual for the general pathologist: Cutaneous lymphomas. Santa Cruz, BO.
2015. Radiation-induced atypical vascular lesions of the breast. Conference. Breast Pathology Course. Lima, PE.
2015. What is new in mammary Paget disease. Conference. Breast Pathology Course. Lima, PE.
2015. Update in the diagnosis of melanoma. Conference. 1st Update in Surgical Pathology. Guatemala City, GT.
2015. A practical approach in the diagnosis of cutaneous lymphomas. Conference. 1st Update in Surgical Pathology. Guatemala City, GT.
2014. Use of molecular pathology in the diagnosis of Melanoma. Conference. Use of molecular pathology in the diagnosis of Melanoma. Arequipa, PE.
2014. Soft Tissue lesions in Dermatopathology: the dermatopathologist approach. Conference. Soft Tissue lesions in Dermatopathology: the dermatopathologist approach. Arequipa, PE.
2014. Dysplastic nevus: definition and controversies. Conference. Dysplastic nevus: definition and controversies. Arequipa, PE.
2014. Lymphoid infiltrates in skin mimicking neoplasms: clinical pathological correlation. Conference. Lymphoid infiltrates in skin mimicking neoplasms: clinical pathological correlation. Arequipa, PE.
2014. Update in the diagnosis of melanoma. Conference. Update in the diagnosis of melanoma. Lima, PE.
2014. Role of inflammation in melanocytic lesions. Conference. 6th Leeds Update on Dermatopathology and Soft Tissue Tumors. Leeds, GB.
2014. Diagnosis of melanoma including molecular testing. Conference. 6th Leeds Update on Dermatopathology and Soft Tissue Tumors. Leeds, GB.
2014. Diagnosis of cutaneous lymphomas: a practical approach. Conference. XXXIV meeting of the Anatomic Pathology Society of Cordoba. Cordoba, AR.
2014. Advances in diagnosis of melanoma. Conference. XXXIV meeting of the Anatomic Pathology Society of Cordoba. Cordoba, AR.
2013. Lymphocytic infiltrates in skin: a practical approach. Conference. Dermatopathology session. XXIX Congress, Latin American Pathology Society. Oaxaca, MX.
2013. Mutational studies in melanoma: what the pathologist must know. Dermatopathology session. Conference. XXIX Congress, Latin American Pathology Society. Oaxaca, MX.
2013. Blastic plasmacytoid dendritic cell lymphoma with concurrent acute myeloid leukemia. Conference. The International Society of Dermatopathology, XXXIV Symposium of The International Society of Dermatopathology. Florence, IT.
2013. Melanocytic lesions of the skin. Conference. National University Health System and The University of Texas MD Anderson Cancer Center Pathology Update Course, SG.
2013. Adnexal tumors of the skin. Conference. National University Health System and The University of Texas MD Anderson Cancer Center Pathology Update Course, SG.
2013. Cutaneous lymphomas. Conference. National University Health System and The University of Texas MD Anderson Cancer Center Pathology Update Course, SG.
2013. Difficult lymphocytic lesions of the Skin: Interesting cases Seminar. Conference. The University of Texas MD Anderson Cancer Center Surgical Pathology Update Course – Peruvian Association of Pathologists – Cayetano Heredia Peruvian University. Lima/Cusco, PE.
2013. Adnexal Tumors of the Skin: Practical Concepts. Conference. The University of Texas M.D. Anderson Cancer Center Surgical Pathology Update Course - Peruvian Association of Pathologists - Cayetano Heredia Peruvian University. Lima/Cusco, PE.
2013. Advances in Molecular Biology of Melanoma. Conference. Hospital Nacional Elgardo Rebagliati Martins. Lima, PE.
2013. Adnexal Tumors of the Skin. Surgical Pathology: Current Concepts. Conference. The University of Texas M.D. Anderson Cancer Center - Cukurova University Medical Faculty. Adana, TR.
2013. Melanocytic Tumors of the Skin, Surgical Pathology: Current Concepts. Conference. The University of Texas M.D. Anderson Cancer Center - Cukurova University Medical Faculty. Adana, TR.
2012. Pathology of Pigmented Lesions of the Skin/Dysplastic nevus: histopathologic diagnosis, architectural and cytologic grading. Conference. International Academy of Pathology. San Jose, CR.
2012. Pathology of Pigmented Lesions of the Skin/Immunohistochemical studies useful in the diagnosis of melanocytic lesions, applications and pitfalls. Conference. International Academy of Pathology. San Jose, CR.
2012. Pathology of Pigmented Lesions of the Skin/Treatment of melanoma: the pathologist contribution to management of melanoma patients. Conference. International Academy of Pathology. San Jose, CR.
2012. Pathology of Pigmented Lesions of the Skin/Interesting cases of melanocytic lesions. Conference. International Academy of Pathology. San Jose, CR.
2012. Lymphocytic infiltrates of the skin: a practical approach. Conference. Peruvian Association of Pathology. Ciudad de Cusco, PE.
2012. Ancillary studies in the diagnosis of melanoma. Conference. Peruvian Association of Pathology. Ciudad de Cusco, PE.
2012. Disseminated Woringer-Kolopp disease. Conference. The International Society of Dermatopathology. Santa Cruz de la Sierra, BO.
2012. When you see a "funny" keratinocytic lesion, think of B-RAF inhibitor therapy effect. Conference. The International Society of Dermatopathology. Santa Cruz de la Sierra, BO.
2012. Metastatic carcinoma mimicking primary cutaneous adnexal tumor. Conference. The International Society of Dermatopathology. Santa Cruz de la Sierra, BO.
2012. Pathology of graft-versus-host disease. Conference. Edgardo Rebagliati National Hospital. Lima, PE.
2012. Controversies in cutaneous lymphomas. Conference. Edgardo Rebagliati National Hospital. Lima, PE.
2012. Primary cutaneous CD30-positive T cell lymphoproliferative disorders. Conference. Edgardo Rebagliati National Hospital. Lima, PE.
2011. Update in Molecular Pathology of Melanoma. Conference. Universidad Peruana Cayetano Heredia. Lima, PE.
2010. CD4-Positive Small/Medium Size Pleomorphic T-cell Lymphoma Primary of the Skin. Conference. CD4-Positive Small/Medium Size Pleomorphic T-cell Lymphoma Primary of the Skin. Cancun, MX.
2010. Adenocarcinoma of the Mammary-like Glands of the Vulva. Conference. Adenocarcinoma of the Mammary-like Glands of the Vulva. Cancun, MX.
2010. Immunohistochemical Studies in Diagnosis, Prognosis and Therapy of Acral Lentiginous Melanoma. Conference. BIT Life Sciences, SG.
2009. Hydroa Vacciniforme-like T cell Lymphoma. Conference. The International Society of Dermatopathology. Santiago, CL.
2006. Update in Prostate Pathology. Conference. Update in Prostate Pathology. Chiclayo, PE.
2006. Update in Cutaneous Lymphomas. Conference. Update in Cutaneous Lymphomas. Chiclayo, PE.
2006. Cutaneous Lymphomas. Conference. Cutaneous Lymphomas. Lima, PE.
2004. The search for new potential markers in ovarian carcinoma through proteomic analysis (Platform Presentation). Conference. The United States and Canadian Academy of Pathology. Vancouver, CA.
2004. Loss of heterozygosity of chromosome 9p21 and expression of p16 protein in acral melanomas (Platform Presentation). Conference. The United States and Canadian Academy of Pathology. Vancouver, CA.

Formal Peers

2024. Lymphomas in the Skin: Primary or Systemic? An Integrated Dermatopathology and Hematopathology Approach. Baltimore, MD, US.
2021. Pineal primary melanoma. Invited. Pineal primary melanoma. London, GB.
2021. Metastatic medullary carcinoma to the skin. Invited. Metastatic medullary carcinoma to the skin. London, GB.
2021. Epidermotropic primary cutaneous γ/δ T cell lymphoma. Invited. Epidermotropic primary cutaneous γ/δ T cell lymphoma. London, GB.
2021. Metastatic triple negative breast carcinoma to the skin: expression to TRPS1. Invited. Metastatic triple negative breast carcinoma to the skin: expression to TRPS1. London, GB.
2021. Extramedullary hematopoiesis-like involvement of the skin by chronic myeloid leukemia. Invited. Extramedullary hematopoiesis-like involvement of the skin by chronic myeloid leukemia. London, GB.
2021. Melanoma arising in neurocristic hamartoma, Multidisciplinary Planning Conference. Invited. Melanoma arising in neurocristic hamartoma, Multidisciplinary Planning Conference. Houston, TX, US.
2020. Melanocytic Lesions. Basic Dermatopathology Course. Invited. Melanocytic Lesions. Basic Dermatopathology Course. Santiago, CL.
2019. Clinical-Pathological Correlation of Dermatological Cases: Expert Panel Member. Invited. Clinical-Pathological Correlation of Dermatological Cases: Expert Panel Member. Lima, PE.
2019. My Best Cases. Invited. My Best Cases. Lima, PE.
2019. What is new in cutaneous T and B cell lymphomas?. Invited. What is new in cutaneous T and B cell lymphomas?. Napa Valley, CA, US.
2019. Biomarkers and ancillary tests in melanocytic lesions. Invited. Biomarkers and ancillary tests in melanocytic lesions. Napa Valley, CA, US.
2019. Role of the dermatopathologist in the management of patients with metastatic melanoma. Invited. Role of the dermatopathologist in the management of patients with metastatic melanoma. Napa Valley, CA, US.
2019. Skin involvement by chronic myelomonocytic leukemia mimicking neutrophilic dermatosis. Invited. Skin involvement by chronic myelomonocytic leukemia mimicking neutrophilic dermatosis. Lisbon, PT.
2019. BAP1-loss associated melanoma. A case presentation and review. Invited. BAP1-loss associated melanoma. A case presentation and review. Lisbon, PT.
2019. Application of immunohistochemical and molecular markers in the evaluation of melanocytic lesions: a cases-based seminar. Invited. Application of immunohistochemical and molecular markers in the evaluation of melanocytic lesions: a cases-based seminar. Bethesda, MD, US.
2018. Update In Cutaneous B-Cell Lymphomas. Invited. Update In Cutaneous B-Cell Lymphomas. Big Island of Hawaii, HI, US.
2018. What is new in cutaneous T-cell lymphomas. Invited. What is new in cutaneous T-cell lymphomas. Big Island of Hawaii, HI, US.
2018. Biomarkers and Ancillary Tests In Melanocytic Lesions: Panel Discussion. Invited. Biomarkers and Ancillary Tests In Melanocytic Lesions: Panel Discussion. Big Island of Hawaii, HI, US.
2018. Staging & CAP Guidelines for Reporting Melanoma, Squamous Cell Carcinoma and Merkel Cell Carcinoma. Invited. Staging & CAP Guidelines for Reporting Melanoma, Squamous Cell Carcinoma and Merkel Cell Carcinoma. Big Hawaii of Island, HI, US.
2018. Role of the Dermatopathologist in the Management of Patients with Metastatic Melanoma. Invited. Role of the Dermatopathologist in the Management of Patients with Metastatic Melanoma. Big Island of Hawaii, HI, US.
2018. Nodal Merkel Cell Carcinoma: a diagnostic challenge. Invited. Nodal Merkel Cell Carcinoma: a diagnostic challenge. Antigua, GT.
2017. Melanocytic lesions of the skin: pathological and molecular tools for diagnosis. Invited. Melanocytic lesions of the skin: pathological and molecular tools for diagnosis. Cordoba, AR.
2016. FISH negative metastatic melanoma: a pitfall. Invited. FISH negative metastatic melanoma: a pitfall. Lima, PE.
2016. Epidermotropic primary cutaneous gamma/delta T cell lymphomas. Invited. Epidermotropic primary cutaneous gamma/delta T cell lymphomas. Cusco, PE.
2016. Hematolymphoid proliferations of the skin: histopathological findings and clinical correlation. Invited. Hematolymphoid proliferations of the skin: histopathological findings and clinical correlation. Bethesda, MD, US.
2014. Gamma/delta T cell lymphoma primary of the skin. Invited. Gamma/delta T cell lymphoma primary of the skin. Arequipa, PE.
2014. Slide seminar on melanocytic tumours. Invited. Slide seminar on melanocytic tumours. Leeds, GB.
2014. Hematolymphoid proliferations of the skin. Case seminar. Invited. Hematolymphoid proliferations of the skin. Case seminar. Cordoba, AR.
2013. Update in Melanocytic Lesions of the Skin. Invited. Update in Melanocytic Lesions of the Skin. Bethesda, MD, US.
2011. Molecular Biology and Update on Melanocytic Lesions of the Skin; Slide seminar on malignant tumors and related conditions of the skin. Invited. Molecular Biology and Update on Melanocytic Lesions of the Skin; Slide seminar on malignant tumors and related conditions of the skin. Lima, PE.
2010. Molecular Pathology in Cutaneous Lymphomas: an update. II Regional Dermatopathology Course. Invited. Molecular Pathology in Cutaneous Lymphomas: an update. II Regional Dermatopathology Course. Arequipa, PE.
2010. Molecular Pathology in Melanoma: the case for KIT and acral lentiginous melanoma. II Regional Dermatopathology Course. Invited. Molecular Pathology in Melanoma: the case for KIT and acral lentiginous melanoma. II Regional Dermatopathology Course. Arequipa, PE.
2010. Dermatopathology Seminar. Invited. Dermatopathology Seminar. Lima, PE.
2009. Dermatopathology Course, Theory and Practice. Invited. Dermatopathology Course, Theory and Practice. Lima, PE.
2008. Update on Cutaneous Lymphomas and Complex Melanocytic Lesions. Invited. Update on Cutaneous Lymphomas and Complex Melanocytic Lesions. Lima, PE.
2006. Dermatopathology Course, Theory and Practice. Invited. Dermatopathology Course, Theory and Practice. Lima, PE.

Less

Grant & Contract Support

Date:	2021 - 2023
Title:	Lymphatic delivery of checkpoint blockade inhibitors for more effective immunotherapy
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	PI
ID:	RP190019

Date:	2020 - 2022
Title:	Molecular Predictors and vulnerabilities of melanoma brain metastasis
Funding Source:	Melanoma Research Alliance
Role:	Co-PI
ID:	687055

Date:	2020 - 2023
Title:	Molecular predictors and vulnerabilities of melanoma brain metastasis
Funding Source:	American Cancer Society (ACS)
Role:	Co-PI
ID:	16MRAT-19-168-01

Date:	2020 - 2023
Title:	Molecular predictors and vulnerabilities of melanoma brain metastasis
Funding Source:	Melanoma Research Alliance
Role:	Co-I
ID:	687055

Date:	2018 - 2021
Title:	Comprehensive molecular and immune profiling of primary acral melanoma from various ethnic groups
Funding Source:	Melanoma Research Alliance
Role:	Mentor

Date:	2014 - 2015
Title:	Biomarkers and Resistance Mechanisms in Melanoma T-Cell Therapy
Funding Source:	NIH/NCI
Role:	Co-I

Date:	2012 - 2014
Title:	Interactive program to identify predictive biomarkers in TIL therapy
Funding Source:	Miriam and Sheldon G Adelson Medical Research Foundation
Role:	Co-I

Date:	2010 - 2015
Title:	SPORE in Melanoma
Funding Source:	NIH/NCI
Role:	Co-I
ID:	P50 CA093459

Date:	2008 - 2013
Title:	Genetic and epigenetics of acral lentiginous melanoma
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	PI

CV information above last modified April 08, 2025

Carlos Antonio Torres-Cabala, M.D.

About Dr. Torres-Cabala

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Research Interests

Clinical Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Editorials

Abstracts

Book Chapters

Books (edited and written)

Letters to the Editor

Selected Presentations & Talks

Local Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Related Links

Translational Molecular Pathology-Dermatopathology Laboratory (TMP-DL)

Help #EndCancer

Carlos Antonio Torres-Cabala, M.D.

About Dr. Torres-Cabala

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Research Interests

Clinical Interests

Education & Training

Degree-Granting Education

Postgraduate Training

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Manuals, Teaching Aids, Other Teaching Publications

Other Articles

Editorials

Abstracts

Book Chapters

Books (edited and written)

Letters to the Editor

Selected Presentations & Talks

Local Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Patient Reviews

Request an Appointment

Related Links

Translational Molecular Pathology-Dermatopathology Laboratory (TMP-DL)

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Volunteer